Devices, systems, devices, and methods for biosensor cross-calibration

Through the cross-calibration method, the background current is predicted and subtracted, the problems of instability and signal artifacts after sensor insertion in CGM systems are solved, which improves the accuracy and life of the sensor and reduces the dependence on blood measurement.

CN118948211APending Publication Date: 2024-11-15KONAMITE LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411030681.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2019-05-09
Filing Date
2020-05-07
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The existing continuous glucose monitoring (CGM) system has unstable performance within the first 12 hours after sensor insertion, signal artifacts and background current changes lead to accuracy problems, affecting the operating life of the system and data reliability.

Method used

The cross-calibration method is used to calibrate the new insertion sensor to improve its accuracy and sensitivity by measuring the current inserted into the sensor and comparing the current of the newly inserted sensor, predicting and subtracting the background current.

Benefits of technology

It effectively solves the initial instability and signal artifacts after sensor insertion, improves the accuracy and sensitivity of the new sensor, extends the sensor's life, and reduces the dependence on actual blood analyte measurements.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118948211A_ABST
    Figure CN118948211A_ABST
Patent Text Reader

Abstract

Devices, systems, devices, and methods for biosensor cross-calibration are disclosed. In some embodiments, an apparatus includes at least one processor configured to perform operations including measuring a first current from a first biosensor and a second current from a second biosensor for a first duration, the first biosensor has been inserted into tissue of a subject before the second biosensor is inserted; converting the first current into a first analyte value; comparing the first current with the second current; and generating a second analyte value for the second biosensor based on the comparison, thereby calibrating the second biosensor.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of the application with national application number 202080049713.0, international application date May 7, 2020, national entry date January 6, 2022, and invention name “System and method for cross-calibration of biosensors”.

[0002] CROSS-REFERENCE TO RELATED APPLICATIONS

[0003] This application claims the benefit of priority to the earlier filing date of U.S. Provisional Patent Application No. 62 / 845,498, filed on May 9, 2019, which is hereby incorporated by reference in its entirety. Technical Field

[0004] Embodiments herein relate to the field of biosensors, and more particularly to calibration of analyte sensors to obtain consistent readings and reduce background artifacts. Background Art

[0005] Continuous sensors, such as continuous glucose monitoring (CGM) sensors, are used to continuously measure data, such as in a continuous data stream and / or as sampled data points within a time interval. Typically, the data is inconsistent over a period of time after insertion, as the sensor adapts to in vivo conditions and background currents stabilize. Currently, all CGM systems require a so-called break-in time, so measurements immediately after sensor insertion are unreliable. Therefore, it would be advantageous if the sensor and associated electronics could compensate for signal artifacts after insertion. Summary of the invention

[0006] According to one aspect of the present disclosure, a device is provided, comprising at least one processor configured to perform operations comprising: measuring a first current from a first biosensor and a second current from a second biosensor over a first duration, the first biosensor having been inserted into tissue of a subject before the second biosensor is inserted; converting the first current into a first analyte value; comparing the first current with the second current; and generating a second analyte value for the second biosensor based on the comparison, thereby calibrating the second biosensor.

[0007] According to another aspect of the present disclosure, a system is provided, comprising: a first glucose biosensor; a second glucose biosensor; and a mobile computing device, the mobile computing device being configured to: receive an indication that the second glucose biosensor has been inserted into the subject, if the first glucose biosensor has been inserted into the subject; initiate a cross-calibration process within a determined amount of time after receiving the indication; obtain a first current from the first glucose biosensor and a second current from the second glucose biosensor; convert the first current into a first glucose value; predict a background current associated with the second glucose biosensor based at least in part on the first current, the second current, and the first glucose value; subtract the background current from the second current to obtain a subtracted second current; create a conversion operation for converting the subtracted second current into a second glucose value, the conversion operation being based at least in part on one or more of the first current and the first glucose value; convert the subtracted second current into the second glucose value based on the conversion operation; and provide a set of instructions related to delivering insulin to the subject based on the second glucose value.

[0008] According to another aspect of the present disclosure, a device is provided, comprising: at least one processor; and a memory storing instructions, which, when executed by the at least one processor, cause the device to perform operations including: detecting that a second sensor is inserted into tissue of an object when a first sensor is inserted into the tissue; in response to the detection, initiating a cross-calibration process for the second sensor; obtaining a first current from the first sensor and a second current from the second sensor; converting the first current into a first analyte value; in response to an indication that a predetermined condition for modeling a first non-glucose driven background current associated with the second sensor is met, predicting the first non-glucose driven background current for the second sensor within a first duration; subtracting the first non-glucose driven background current from the second current during the first duration to obtain a subtracted second current for the second sensor; and converting the subtracted second current into a second analyte value.

[0009] According to another aspect of the present disclosure, a method is provided, comprising: after inserting a first analyte sensor into the skin of an object, detecting that a second analyte sensor has been inserted into the skin of the object, wherein the insertion of the first analyte sensor occurs between one day and thirty days before the second analyte sensor is inserted; initiating a cross-calibration process based on the detection; retrieving a first current from the first analyte sensor and retrieving a second current from the second analyte sensor, and converting the first current into a first analyte value within five to sixty seconds of initiating the cross-calibration process; within sixty seconds to one hour after initiating the cross-calibration process, determining that a current decay trend can be established for the second analyte sensor based on the second current, and in response, predicting an inferred background current over a duration based at least in part on the second current measured within sixty seconds to one hour after initiating the cross-calibration process; subtracting the background current from the second current over the duration to obtain a subtracted second current; and converting the subtracted second current into a second analyte value, thereby calibrating the second analyte sensor.

[0010] According to yet another aspect of the present disclosure, a method, system, apparatus, and computer-readable medium are provided for calibrating an analyte sensor when the analyte sensor is inserted into a subject's tissue, based at least in part on parameters obtained from another analyte sensor that has been calibrated and was previously inserted into the subject's tissue. As an example, the method may include: predicting a background current associated with the newly inserted sensor; subtracting the background current from the current measured by the newly inserted sensor; and converting the subtracted current to a glucose value, the conversion being based at least in part on parameters obtained from the previously inserted analyte sensor. In this way, the newly inserted sensor can be calibrated without relying on actual blood-based analyte measurements, and the accuracy and sensitivity of the newly inserted sensor can be improved. BRIEF DESCRIPTION OF THE DRAWINGS

[0011] The embodiments will be readily understood from the following detailed description and the appended claims taken in conjunction with the accompanying drawings. Embodiments are illustrated by way of example and not limitation in the figures of the accompanying drawings.

[0012] Figure 1 is a schematic diagram of a networked CGM system for cross-calibration of analyte sensors according to embodiments herein.

[0013] Figure 2 is a flow chart illustrating an example method for cross-calibrating a sensor using a computing device according to disclosed embodiments.

[0014] Figure 3 is used to determine whether the sensor has been Figure 2 A flow chart of an example method of effectively cross-calibrating a method.

[0015] Figure 4 It is shown Figure 2 An indicative example timeline of a cross-calibration approach.

[0016] Figure 5 It is to illustrate Figure 2 Schematic diagram of the experimental procedure performed to test the effectiveness of the cross-calibration method.

[0017] Figure 6 is a graph showing glucose concentration determined by a continuous glucose monitor (CGM) with a calibrated analyte sensor (CGM#B0) and glucose concentration determined by a blood glucose meter according to various aspects described herein.

[0018] Figure 7 is a graph showing glucose concentration as determined by a CGM having an analyte sensor (CGM#H13) and a glucose concentration determined by a blood glucose meter according to various aspects described herein, the analyte sensor (CGM#H13) having been measured relative to Figure 6 The analyte sensor depicted in (CGM#B0) was cross-calibrated.

[0019] Figure 8 is a graph showing glucose concentration as determined by a CGM having an analyte sensor (CGM#G4) relative to a blood glucose level determined by a blood glucose meter according to various aspects described herein. Figure 6 The analyte sensor depicted in (CGM#B0) was cross-calibrated.

[0020] Fig. 9A is a graph showing raw, uncalibrated analyte sensor signal (line) versus actual blood glucose readings (dots).

[0021] Fig. 9B is a graph showing calibrated analyte sensor signal (line) versus actual blood glucose readings (dots). DETAILED DESCRIPTION

[0022] In the following detailed description, reference is made to the accompanying drawings, which form a part of the detailed description and in which embodiments that can be practiced are shown by way of illustration. It should be understood that other embodiments can be used and structural or logical changes can be made without departing from the scope. Therefore, the following detailed description should not be regarded as having a limiting meaning.

[0023] Various operations may be described as multiple discrete operations in turn in a manner that may clarify the embodiments; however, the order of description should not be construed as to imply that these operations are order dependent.

[0024] The description may use perspective-based descriptions, such as up / down, back / front, and top / bottom. Such descriptions are only used to facilitate discussion and are not intended to limit the application of the disclosed embodiments.

[0025] The terms "coupled" and "connected," as well as their derivatives, may be used. It should be understood that these terms are not intended to be synonymous with each other. Rather, in particular embodiments, "connected" may be used to indicate that two or more elements are in direct physical or electrical contact with each other. "Coupled" may mean that two or more elements are in direct physical or electrical contact. However, "coupled" may also mean that two or more elements are not in direct contact with each other, but still cooperate or interact with each other.

[0026] For the purposes of the description, a phrase in the form “A / B” or in the form “A and / or B” means (A), (B), or (A and B). For the purposes of the description, a phrase in the form “at least one of A, B, and C” means (A), (B), (C), (A and B), (A and C), (B and C), or (A, B, and C). For the purposes of the description, a phrase in the form “(A)B” means (B) or (AB), that is, A is an optional element.

[0027] The description may use the term "embodiment" or "embodiments", which may refer to one or more of the same or different embodiments. In addition, the terms "including", "comprising", "having", etc. used with respect to the embodiments are synonymous and are generally intended to be "open" terms (e.g., the term "including" should be interpreted as "including but not limited to", the term "having" should be interpreted as "having at least", the term "including" should be interpreted as "including but not limited to", etc.).

[0028] With regard to the use of any plural and / or singular terms herein, those skilled in the art may convert from the plural to the singular and / or from the singular to the plural as the context and / or application permits. For clarity, various singular / plural permutations may be explicitly set forth herein.

[0029] Continuous glucose monitoring (CGM) technology has been used in the management of diabetes for many years. Conventional devices (e.g., sensors) use enzymatic methods (e.g., based on glucose oxidase converting glucose into hydrogen peroxide that reacts with platinum to generate an electrical signal) to measure glucose concentration and provide sample information. In some applications, CGM sensors can be key components of closed-loop insulin delivery systems, so CGM sensors must be selective, fast, predictable, and acceptable for continuous patient use.

[0030] Some of the issues facing the continued development of continuous CGM systems include, but are not limited to, calibration requirements for inserted glucose sensors and unstable performance of glucose sensors within the first 12 hours after insertion. During this 12-hour period, several factors may lead to unstable performance of the sensor. One example includes the balance of skin / tissue damage processes to the inserted sensor. Another example includes preheating of stable phenomena associated with the sensor. Yet another example includes the presence of interstitial fluid components (e.g., proteins) deposited on the exterior of the sensor over time. Additional examples include acute and / or chronic immune responses that occur in the subject in response to sensor insertion. Such processes may have an impact on the type and quality of the signal generated by the sensor.

[0031] Other issues with the accuracy of CGM sensors involve signal artifacts and dynamic sensor behavior changes over time. The operational life of current CGM systems is about 14 days or less. However, increasing the wearing time to at least 20 days or more, or even 30 days or more may be desirable.

[0032] The inventors herein have recognized the above problems and have developed methods and systems that at least partially solve them. Therefore, embodiments herein provide a method for biosensor calibration. The method includes starting a cross-calibration process and, within a first duration, measuring a first current from a first biosensor and measuring a second current from a second biosensor, the first biosensor having been inserted into the tissue of a subject before inserting the second biosensor. The method also includes: converting the first current into a first analyte value; comparing the first current with the second current; and obtaining a second analyte value based on the comparison. In this way, the second biosensor can be calibrated. It will be understood that the first analyte value may include one or more first analyte values, and the second analyte value may include one or more second analyte values.

[0033] For the method, the first biosensor may be inserted into the subject's tissue at least one day but less than thirty days prior to inserting the second biosensor. The first biosensor may be calibrated prior to initiating the cross-calibration, and the calibration of the first biosensor may be based on one or more actual blood analyte values ​​obtained from the subject's blood. The first duration may be at least one minute but no more than sixty minutes, and the conversion of the first current to the first analyte value may occur between five seconds and sixty seconds from the start of the first duration.

[0034] For the method, comparing the first current with the second current and obtaining the calibrated current may also include predicting a first background current during a second duration, the first background current being a portion of the second current as a function of time, the second duration extending beyond the first duration. The method may also include: subtracting the background current from the second current during the second duration to obtain the subtracted second current; and creating a conversion operation for converting the subtracted second current into the second analyte value based at least in part on the subtracted second current, the first current, and one or more of the first analyte value. Each of the first current and the second current may also continue to be measured during the second duration. In some examples, the background current may be predicted based at least in part on one or more of the second current, the first current, and the first analyte value. In some examples, the second duration extends to twelve hours after the second biosensor is inserted. In some examples, the method also includes: retrieving historical data related to the analyte sensitivity of one or more other biosensors previously worn by the subject; and applying a correction factor derived from the analyte sensitivity when generating the second analyte value to improve the sensitivity of the second biosensor.

[0035] For the method, comparing the first current with the second current and generating the second analyte value may also include predicting a second background current within a third duration, the second background current being a portion of the second current as a function of time. The third duration may extend beyond the first duration and the second duration, and the second current may continue to be measured during the third duration. The method may include subtracting the second background current from the second current measured within the third duration to obtain the subtracted second current; and generating a second analyte value for the second biosensor using a conversion process based on the subtracted second current determined during the third duration as input. In such an example, the second background current may be based on data collected from any number of biosensors of the same type as the first biosensor and / or the second biosensor, and the data is related to the background current in the second biosensor within the third duration. In some examples, the third duration may extend to the following period after the second biosensor is inserted: greater than 15 days, or greater than 20 days (e.g., 21 days), or greater than 25 days, or greater than 30 days (e.g., 31 days). In this way, an accurate second analyte value may be obtained throughout the life of the second sensor.

[0036] For this method, each of the first biosensor and the second biosensor may include a glucose biosensor, and in such an example, the first analyte value and the second analyte value may be understood to correspond to glucose values.

[0037] In another embodiment, a system for delivering insulin to a subject in need is provided. The system may include a first glucose biosensor, a second glucose biosensor, and a mobile computing device. The mobile computing device may include a processor, and the processor may store instructions in a non-volatile memory, which instructions, when executed, cause the processor to: receive a notification that a second glucose biosensor has been inserted into the subject when the first glucose biosensor has been inserted into the subject; and initiate a cross-calibration process within a determined amount of time after receiving the indication. The instructions may also cause the processor to: obtain a first current from the first glucose sensor and a second current from the second biosensor; convert the first current into a first glucose value; and predict a background current associated with the second sensor based at least in part on one or more of the first current, the second current, and the first glucose value. The instructions may also cause the processor to: subtract the background current from the second current to obtain a subtracted second current; and convert the calibrated current into a second glucose value. The instructions may also cause the processor to provide an instruction set related to delivering insulin to the subject based on the second glucose value. For such a system, it is understood that the first glucose value may include one or more first glucose values, and the second glucose value may include one or more second glucose values.

[0038] In an example of the system, the system may also include an insulin delivery unit in communication with the mobile computing device, the insulin delivery unit including at least an insulin pump and an infusion set fluidly coupled to the insulin pump via tubing. In such an example, the processor of the mobile computing device may store additional instructions to send an instruction set related to delivering insulin to a subject to the insulin delivery unit for delivering insulin to the subject via the infusion set by controlling the operation of the insulin pump.

[0039] For such a system, in additional or alternative examples, the mobile computing device may also include a display.The processor of the mobile computing device may store further instructions to communicate, via the display, a set of instructions related to delivering insulin to a subject.

[0040] For such a system, the processor of the mobile computing device may store additional instructions to compare the first glucose value to the second glucose value. In response to an indication that the second glucose value is correlated within a predetermined threshold of the first glucose value, a set of instructions related to delivering insulin to the subject based on the second glucose value may be provided. For such a system, the processor of the mobile computing device may store additional instructions to provide an alert to the subject that the first glucose biosensor may be removed in response to an indication that the second glucose value is correlated within a predetermined threshold of the first glucose value.

[0041] For such a system, the processor of the mobile computing device may store additional instructions to: predict the background current between one minute and 60 minutes after the cross-calibration process is initiated; and subtract the background current from the second current for scaling the second current to the first current for up to two days after the cross-calibration process is initiated. However, it will be appreciated that, as discussed with respect to other embodiments herein, in some examples, the background current (the second background current) may continue to be subtracted from the second current over a period of 15 to 30 days or even slightly longer (e.g., 31 days, 32 days, 33 days, 34 days, 35 days, etc.). In such examples that include a longer period of time, it will be appreciated that the background current (e.g., the second background current) may be modeled based on relevant data obtained from one or more earlier worn sensors of a similar type to each of the first glucose biosensor and the second glucose biosensor.

[0042] Embodiments herein also provide a device for calibrating a biosensor inserted into the tissue of an object. The device may include a mobile computing device including a processor having instructions stored in a non-transitory memory. The instructions, when executed, may cause the processor to: detect that a second sensor is inserted into the tissue of the object when the first sensor is inserted into the tissue; and initiate a cross-calibration process of the second sensor in response to the detection. The instructions may also cause the processor to obtain a first current from the first sensor and a second current from the second sensor, and convert the first current into a first analyte value. In response to an indication that a predetermined condition for modeling a non-glucose-driven background current associated with the second sensor is satisfied, the instructions may cause the processor to predict a non-glucose-driven background current for the second sensor within a predetermined duration. During the predetermined duration, the instructions may cause the processor to: subtract the non-glucose-driven background current from the second current to obtain a subtracted second current for the second sensor; and convert the subtracted second current into a second analyte value. For such a device, it is understood that the first analyte value may include one or more first analyte values, and the second analyte value may include one or more second analyte values.

[0043] For such a device, the processor may store additional instructions to predict the non-glucose driven background current based on a second current measured before the predetermined condition is satisfied and based at least in part on one or more of the first current and the first analyte value obtained before the predetermined condition is satisfied. In some additional or alternative examples, the processor may store additional instructions to predict the non-glucose driven background current based on previously generated patterns of background current changes learned over time from multiple other analyte sensors inserted into the subject at an earlier time.

[0044] For such a device, in an example, an indication that a predetermined condition for modeling a non-glucose-driven background current is satisfied may occur between one minute and sixty minutes after the cross-calibration process is initiated. In addition, the predetermined duration of subtracting the non-glucose-driven background current from the second current may be at least two hours and up to sixty-four hours. In some examples, the non-glucose-driven background current may be modeled over more than sixty-four hours, for example, the entire wearing time of the second sensor. Such long-term modeling of background current may rely on a learned background current associated with a previous sensor of the same type previously worn by the same subject. The entire wearing time of the sensor of the present disclosure may be 21 days or longer. In one example, the entire wearing time of the sensor of the present disclosure may include thirty days, or a duration between 30 and 35 days.

[0045] For such a device, obtaining the subtracted second current and converting the subtracted second current into a second analyte value may also include the following. Specifically, via additional instructions stored in the non-transient memory of the processor, the processor can call one or more previously learned analyte sensitivity values ​​from the previous use of the object to other analyte sensors, and a correction process can be applied to obtain accurate analyte sensitivity for the second sensor. For example, the sensitivity change as discussed herein can be understood to be related to the change (e.g., nA / (mg / dL)) of the measured current as a function of the change in analyte concentration. Therefore, it can be understood that in addition to the long-term modeling of the background current as discussed above, the sensitivity change learned from one or more sensors previously worn by the same object can be similarly modeled (e.g., using up to 30 days). Long-term modeling of sensitivity changes can then be used, such as via a correction process that relies on one or more values ​​obtained via long-term modeling of sensitivity changes, to obtain accurate analyte sensitivity for the second sensor when the second sensor is worn. In this way, the device can provide a calibration method that does not rely on blood analyte measurements for calibration, even for sensors that are worn for up to 30 days and even more than 30 days. Embodiments herein also provide a non-transient computer-readable storage medium on which an executable program for biosensor calibration is stored. The executable program may instruct a microprocessor to perform one or more steps. One step may include, after inserting the first analyte sensor into the skin of the object, detecting that the second analyte sensor has been inserted into the skin of the object, wherein the insertion of the first analyte sensor occurs between one day and thirty days before the second analyte sensor is inserted. Another step may include starting a cross-calibration process based on the detection. Another step may include retrieving a first current from the first analyte sensor and retrieving a second current from the second analyte sensor, and converting the first current into a first analyte value within five to sixty seconds of starting the cross-calibration process. Another step may include determining that a current decay trend can be established for the second analyte sensor within sixty seconds to one hour after starting the cross-calibration process. In response, another step may include predicting a background current (e.g., a first background current) inferred within a predetermined duration based at least in part on a second current measured within sixty seconds to one hour after starting the cross-calibration process. Another step may include subtracting a background current distribution from the second current within a predetermined duration to obtain a subtracted second current. Another step may include converting the subtracted second current into a second analyte value, thereby calibrating the second analyte sensor.For such non-transitory computer readable storage media, it is understood that the first analyte value may include one or more first analyte values, and the second analyte value may include one or more second analyte values.

[0046] For such a non-transitory computer readable storage medium, the executable program may store additional instructions to continue converting the first current into a first analyte value during a predetermined duration (provided that the first analyte sensor remains embedded in the subject's skin). The instructions may also include comparing the first analyte value during the predetermined duration to a second analyte value. The instructions may also include determining that the second analyte sensor is effectively calibrated in response to the first analyte value obtained during the predetermined duration being correlated within a predetermined threshold of the second analyte value.

[0047] For such a non-transitory computer readable storage medium, the executable program may store additional instructions to determine an appropriate amount of insulin to be injected into the subject based on the second analyte value, wherein each of the first analyte sensor and the second analyte sensor is a glucose biosensor.

[0048] For such non-transient computer-readable storage media, the predetermined duration may be included between one hour and twelve hours. However, in other examples, the predetermined duration may be included between one hour and 30 days (or even up to 35 days). For example, in the case where the predetermined duration is extended beyond at least 6 hours, or at least 12 hours, or at least 20 hours, or at least 24 hours, then the second background current may be determined to continue to subtract the second measured current from the second background current similar to that discussed above. The second background current may be determined based on historical data retrieved from one or more other sensors of the same type previously worn by the object. In this way, in some examples, the sensor life may be, for example, extended to 30 days or even longer.

[0049] In addition, for such a non-transitory computer-readable storage medium, the executable program may store additional instructions to generate an analyte sensitivity based at least in part on a second analyte value for a second analyte sensor during a predetermined time period; retrieve one or more analyte sensor performance parameters from a previous analyte sensor wearing period of the subject, the one or more analyte sensor performance parameters including an analyte sensitivity determination data set corresponding to a plurality of previously worn analyte sensors and a background current data set; and implement one or more correction processes that rely on one or more of the background current data set and the analyte sensitivity determination data set to improve the accuracy of the analyte sensitivity for the second analyte sensor. Such a process may improve performance and may additionally or alternatively be used to reduce or eliminate any blood calibration steps associated with using the second analyte sensor. It is understood that the analyte sensitivity determination data set may include analyte sensitivity determinations from any number of sensors of the same type previously worn by the subject. The analyte sensitivity determinations may be averaged or otherwise processed, such as via a machine learning or deep learning method, to learn changes in analyte sensitivity over time, which may then be used to improve the sensitivity of the sensor currently worn by the subject.

[0050] With respect to the embodiments discussed above, it has been recognized herein that trends exist in the signals of analyte sensors occurring during and after the initial 12 hours following sensor insertion and / or activation. Trends include, but are not limited to, changes in background current and changes in sensor sensitivity, both occurring over time.

[0051] Background current as discussed herein refers to the electric current observed in a multi-electrode system (for example, two or three electrode systems), such as the electric current that is usually relied on in a glucose sensor and is not directly related to the measurement of glucose levels. This signal may start very high in a few minutes immediately after the sensor is inserted into the skin, and then gradually experience an exponential decline (with reference to Example 2 below) in the following 6 to 12 hours. After this initial decline, the non-glucose related background signal may still vary with time, but the degree of variation is less compared with the first 12 hours. As an example, the pattern of the background current signal after the glucose sensor is inserted can be a sharp decline of about the first 6 hours, followed by a relatively slow decline (shallower drop) in the following 6 hours. Then, in the following 5 to 6 days, the current signal can continue to decline at a much slower speed and in a more linear manner. Then, the third pattern can be immersed, and that is, the background current signal gradually rises from about the 5th day to about the 30th day. There are also other patterns that may occur equally, but are not easy to model based on initial decay or decline.

[0052] Generating a model of the behavior of this background or non-glucose related current (NGC) requires a large amount of high-quality data. This can be difficult to measure in an in vivo setting because there may be no independent check on what caused the current to drop, such as whether the current drop is based on a drop in glucose or whether it includes a true change in the NGC signal. Typically, such a check requires the use of a blood glucose meter to determine blood glucose levels. As discussed herein, a blood glucose meter refers to a system whereby a subject pricks their finger to obtain a drop of blood, and then applies the drop of blood to a handheld device that indicates the actual blood glucose level.

[0053] To address the difficulty of obtaining reliable data within this first 12 hour window, the inventors have developed a crossover calibration method (also referred to as a cross-calibration method) herein to distinguish between glucose level modulated current and non-glucose related current (NGC). In addition, the disclosed method allows the sensitivity of a newly inserted sensor to be calibrated using one or more glucose values ​​determined by a sensor that has been working in the body for a period of time, such as a glucose sensor that has been calibrated by the disclosed method or another method (e.g., calibrated by comparing with actual blood glucose determination (e.g., tester blood glucose determination)). This calibration method for converting current values ​​from a new sensor into one or more glucose values ​​can be performed without the need for a separate blood glucose analysis. Therefore, the method discussed herein enables serial calibration of analyte sensors, and in some embodiments, can be continued over the life of the subject or some shorter period of time.

[0054] The ability to correct or model changes in background current and sensor sensitivity that occur over time, either individually or cumulatively, can have a significant impact on the performance of the system. However, to date, previous approaches have been of limited value. It is well documented that continuous glucose monitor (CGM) sensors typically perform 30% to 50% worse on the first day than on any other day, for example in terms of median absolute relative deviation (MARD) or mean absolute deviation (MAD) analysis. For example, during a recent study described in more detail below, the inventors evaluated the MARD observed during the first day of clinical practice versus the performance of the second clinical day, which is typically the fourth day of a clinical study. The MARD number on the first day was 17.7%, while the number on day 4 was 10.5%.

[0055] Briefly, the study was conducted using 15 subjects in a seven-day sensor wearing study. Each subject was asked to wear two sensors and carry a receiving device. The CGM sensor was inserted in the morning of the first day. Each subject then drew blood at 15-minute intervals over the next 12 hours. A glucose analyzer (Yellow Springs Instrument) was used to determine the glucose concentration of the plasma from the drawn blood. The first plasma glucose concentration between 90 and 180 mg / dl was used to calibrate the CGM sensor. These values ​​are used to convert the CGM current value into a blood glucose equivalent glucose value.

[0056] The subjects continued to wear the CGM device for the next three days. On Day 4, blood was drawn repeatedly at 15-minute intervals over a 12-hour period in a manner similar to Day 1. The subjects continued to wear the CGM device for the next three days. On Day 7, another 12-hour blood sampling and testing was completed. At the end of 12 hours, the sensor was removed and the study was terminated. The accuracy analysis of this study was based on comparing the glucose concentrations generated by the CGM with the glucose concentrations generated on the YSI using a venously drawn blood sample. Each day was treated as a separate data set, and MARD and MAD values ​​were generated each day. Based on these assessments, the average MARD was determined for Day 1 and for Day 4. Taking into account the rapid changes that occur on Day 1 after the sensor is inserted, the MARD on Day 1 is typically much higher than the MARD on Day 4 or Day 7.

[0057] Steering Figure 1, an example networked continuous analyte monitoring (CAM) system 100 according to embodiments herein is disclosed herein. In an example in which the CAM system 100 is used to monitor glucose levels in a subject over time, the CAM system may be referred to as a continuous glucose monitoring (CGM) system 100. The networked CAM system 100 includes an analyte sensor computing device 105 that communicates wired or wirelessly with one or more analyte sensing devices 107 via a network 115. As discussed herein, one or more analyte sensing devices 107 may also be referred to as analyte sensors, or simply sensors. In an example in which the analyte sensor includes a glucose sensor, the analyte sensor may be referred to as a CGM sensor, a glucose sensor, or simply a sensor. The networked CAM system 100 may also include other networked devices 110 (e.g., laptop computers, desktop computers, tablet computers, smart phones, servers, mass storage devices, etc.), which may communicate wired or wirelessly with the analyte sensor computing device 105 and / or one or more analyte sensors 107 via a network 115. In some embodiments, the analyte sensor computing device 105 includes application software having executable instructions configured to send and receive information from the network 115. The information can be sent to and / or received from another device (e.g., one or more networked devices 110) via the network 115. In certain examples, the analyte sensor computing device 105 can also send information about analyte measurements retrieved from the subject's one or more analyte sensors 107 to one or more of a physician, other medical practitioner.

[0058] like Figure 1 As depicted, the CAM system 100 distributes information to and receives information from one or more networked devices (e.g., analyte sensor computing device 105, networked device 110) via one or more networks 115. According to various embodiments, the network 115 may be any network that allows computers to exchange data, such as for cloud-based storage of generated data (historical and current) and / or to implement some, none, or even all of the methods disclosed herein. Figure 1Depicted is a database 180, which in some examples may include a cloud-based data storage device. In some embodiments, the network 115 includes one or more network elements (not shown) that can physically or logically connect a computer. The network 115 may include any appropriate network, including an intranet, the Internet, a cellular network, a local area network (LAN), a wide area network (WAN), a personal network, or any other such network or combination thereof. The components used for such a system may depend at least in part on the selected network type and / or environment. The protocols and components used to communicate via such a network are well known and will not be discussed in detail herein. In an embodiment, the communication performed by the network 115 is achieved by wired or wireless connections and combinations thereof. The network 115 includes a wired or wireless telecommunications device through which the network system can transmit and exchange data. For example, the network 115 is implemented as or may be part of a storage area network (SAN), a personal area network (PAN), a metropolitan area network (MAN), a local area network (LAN), a wide area network (WAN), a wireless local area network (WLAN), a virtual private network (VPN), an intranet, the Internet, a mobile phone network (e.g., Global System for Mobile Communications (GSM), General Packet Radio Service (GPRS), cdmaOne, CDMA2000, Evolution-Data Optimized (EV-DO), Enhanced Data Rates for GSM Evolution (EDGE), Universal Mobile Telecommunications System (UMTS), Digital Enhanced Cordless Telecommunications (DECT), Digital AMPS (IS-136 / TDMA), Integrated Digital Enhanced Network (iDEN), Long Term Evolution (LTE), third generation mobile networks (3G), fourth generation mobile networks (4G), and / or fifth generation mobile networks (5G) networks), a card network, Bluetooth, a near field communication network (NFC), any form of standardized radio frequency, or any combination thereof, or any other suitable architecture or system that facilitates the transmission of signals, data, and / or messages (commonly referred to as data). Throughout this specification, it should be understood that the terms "data" and "information" are used interchangeably herein to refer to text, images, audio, video or any other form of information that may exist in a computer-based environment.

[0059] In an example embodiment, each of the analyte sensor computing device 105 and the networked device 110 may include a device having a communication component capable of sending and / or receiving data over the network 115. For example, each networked device 110 may include a server, a personal computer, a mobile device (e.g., a laptop, tablet, netbook computer, a personal digital assistant (PDA), a video game device, a GPS locator device, a cellular phone, a smart phone, or other mobile device), a television having one or more processors embedded therein and / or coupled to one or more processors, or other appropriate technology including or coupled to a web browser or other application for communicating via the network 115.

[0060] According to embodiments herein, the analyte sensor computing device 105 may be a device for detecting a sensor (eg, Figure 1 In an embodiment, the analyte sensor computing device 105 includes several components, such as one or more processors 140 and, for example, a processor that can communicate with a sensor (e.g., Figure 1At least one sensor communication module 142 for communicating with an analyte sensor 107 of the present invention. In various embodiments, the one or more processors 140 each include one or more processor cores. In various embodiments, at least one sensor communication module 142 is physically and electrically coupled to the one or more processors 140. In various embodiments, at least one sensor communication module 142 is physically and / or electrically coupled to one or more sensors, such as a first and / or second analyte sensor. In some examples, it is understood that the analyte sensor computing device 105 and the analyte sensor 107 may include a single device without departing from the scope of the present disclosure. In other implementations, the sensor communication module 142 is part of one or more processors 140. In various embodiments, the analyte sensor computing device 105 includes a printed circuit board (PCB) 155. For these embodiments, the one or more processors 140 and the sensor communication module 142 are disposed on the printed circuit board 155. The analyte sensor computing device 105 includes other components that may or may not be physically and electrically coupled to the PCB according to its application. These other components include, but are not limited to, a memory controller (not shown), a volatile memory (e.g., a dynamic random access memory (DRAM) (not shown)), a non-volatile memory (not shown, such as a read-only memory (ROM), a flash memory (not shown)), an I / O port (not shown), a digital signal processor (not shown), an encryption processor (not shown), a graphics processor (not shown), one or more antennas (not shown), a touch screen display 110, a touch screen display controller (not shown), a battery (not shown), an audio codec (not shown), a video codec (not shown), a global positioning system (GPS) device (not shown), a compass (not shown), an accelerometer (not shown), a temperature monitor, a gyroscope (not shown), a speaker (not shown), a camera device (not shown), and a mass storage device (e.g., a hard disk drive, a solid-state drive, a compact disk (CD) (not shown), a digital versatile disk (DVD) (not shown)), a microphone (not shown), etc.

[0061] In some embodiments, one or more processors 140 are operably coupled to the system memory via one or more links (e.g., interconnects, buses, etc.). In an embodiment, the system memory can store information used by one or more processors 140 to operate and execute programs and operating systems, including computer-readable instructions for the methods disclosed herein. In different embodiments, the system memory is a readable and writable memory of any available type, such as in the form of a dynamic random access memory (DRAM). In an embodiment, the analyte sensor computing device 105 includes various input and output / feedback devices or is otherwise associated with various input and output / feedback devices so that a user can interact with the analyte sensor computing device 105 and / or peripheral components or devices associated with the analyte sensor computing device 105 through one or more user interfaces or peripheral component interfaces. In an embodiment, the user interface includes, but is not limited to, a physical keyboard or keypad, a touchpad, a display device (touch screen or non-touch screen), a speaker, a microphone, a sensor (e.g., a glucose sensor), a tactile feedback device, and / or one or more actuators, etc.

[0062] In some embodiments, the analyte sensor computing device 105 may include a memory element (not shown), which may be present in a removable smart chip or a secure digital ("SD") card, or it may be embedded in a fixed chip. In certain example embodiments, a subscriber identity component ("SIM") card may be used. In various embodiments, the memory element may allow software applications to reside on the device.

[0063] In an embodiment, the I / O link connecting the peripheral device to the analyte sensor computing device 105 is protocol-specific, having a protocol-specific connector port that allows a compatible peripheral device to be attached to a protocol-specific connector port via a protocol-specific cable (i.e., a USB keyboard device will be plugged into a USB port, a router device will be plugged into a LAN / Ethernet port, etc.). Any single connector port will be limited to peripheral devices with compatible plugs and compatible protocols. Once a compatible peripheral device is plugged into the connector port, a communication link is established between the peripheral device and the protocol-specific controller.

[0064] In an embodiment, the non-protocol specific connector port is configured to couple the I / O interconnect with the connector port of the analyte sensor computing device 105, thereby allowing multiple device types to be attached to the analyte sensor computing device 105 through a single physical connector port. In addition, the I / O link between the analyte sensor computing device 105 and the I / O complex is configured to carry multiple I / O protocols (e.g., PCI In various embodiments, the connector port can provide the full bandwidth of the link in both directions without sharing bandwidth between ports or between upstream and downstream directions. In various embodiments, the connection between the I / O interconnect and the analyte sensor computing device 105 supports electrical connection, optical connection, or both.

[0065] In some embodiments, the one or more processors 140, flash memory, and / or storage device include associated firmware storing programming instructions configured to enable the analyte sensor computing device 105 to practice, in response to execution of the programming instructions by the one or more processors 140, the analyte sensor computing device 105 to perform a method of using the computing device to perform a sensor (e.g., Figure 1 All or selected aspects of a method for cross-calibrating an analyte sensor).

[0066] In embodiments, the sensor communication module 142 may enable wired and / or wireless communications to transmit data to and from the analyte sensor computing device 105, such as to and / or from one or more sensors (e.g., Figure 1 analyte sensor 107) transmits data. As an example, the sensor communication module 142 may include a transmitter and / or a transmitter / receiver. In some examples, the transmitter and / or the transmitter / receiver may be, for example, physically and / or electrically coupled to one or more sensors (e.g., a glucose sensor).

[0067] In various embodiments, the analyte sensor computing device 105 also includes a network interface that is configured to connect the analyte sensor computing device 105 to one or more networked computing devices wirelessly via a transmitter and a receiver (or optionally a transceiver), and / or via a wired connection using a communication port. In an embodiment, the network interface and the transmitter / receiver and / or the communication port are collectively referred to as a "communication module". In an embodiment, the wireless transmitter / receiver and / or the transceiver may be configured to operate according to one or more wireless communication standards. The term "wireless" and its derivatives may be used to describe circuits, devices, systems, methods, techniques, communication channels, etc. that can transmit data via a non-solid medium by using modulated electromagnetic radiation. The term does not imply that the associated device does not contain any wiring, although in some embodiments it may not contain any wiring. In an embodiment, the analyte sensor computing device 105 includes a wireless communication module for sending and receiving data, such as for sending and receiving data from a network such as a telecommunications network. In an example, the communication module sends data including video data through a cellular network or mobile network such as: Global System for Mobile Communications (GSM), General Packet Radio Service (GPRS), cdmaOne, CDMA2000, Evolution Data Optimized (EV-DO), Enhanced Data Rates for GSM Evolution (EDGE), Universal Mobile Telecommunications System (UMTS), Digital Enhanced Cordless Telecommunications (DECT), Digital AMPS (IS-136 / TDMA) and Integrated Digital Enhanced Network (iDEN), Long Term Evolution (LTE), third generation mobile networks (3G), fourth generation mobile networks (4G) and / or fifth generation mobile networks (5G) networks. In an embodiment, the computing device 100 is directly connected to one or more devices via a direct wireless connection using, for example, Bluetooth and / or BLE protocols, WiFi protocols, infrared data association (IrDA) protocols, ANT and / or ANT+ protocols, LTE ProSe standards, etc. In an embodiment, the communication port is configured to operate according to one or more known wired communication protocols, such as a serial communication protocol (e.g., Universal Serial Bus (USB), FireWire, Serial Digital Interface (SDI), and / or other similar serial communication protocols), a parallel communication protocol (e.g., IEEE 1284, Computer Automatic Measurement and Control (CAMAC), and / or other similar parallel communication protocols), and / or a network communication protocol (e.g., Ethernet, Token Ring, Fiber Distributed Data Interface (FDDI), and / or other similar network communication protocols).

[0068] In embodiments, the analyte sensor computing device 105 is configured to run, execute, or otherwise operate one or more applications. In embodiments, the applications include native applications, web applications, and hybrid applications. For example, a native application is used to operate the analyte sensor computing device 105, a sensor coupled to the analyte sensor computing device 105 (e.g., Figure 1 The native applications may be platform specific or non-platform or operating system (OS) specific. In an embodiment, the native applications are developed for a specific platform using platform specific development tools, programming languages, etc. Such platform specific development tools and / or programming languages ​​are provided by the platform vendor. In an embodiment, the native applications are pre-installed on the analyte sensor computing device 105 during manufacturing or are downloaded by an application server via a network (e.g., Figure 1 The web application is provided to the analyte sensor computing device 105 via the network 115 of the service provider. The web application is an application loaded into the web browser of the analyte sensor computing device 105 in response to a request for the web application from the service provider. In an embodiment, the web application is a website designed or customized to run on the computing device by considering various computing device parameters (e.g., resource availability, display size, touch screen input, etc.). In this way, the web application can provide an experience similar to that of a native application in a web browser. The web application can be any server-side application developed using any server-side development tool and / or programming language (e.g., PHP, Node.js, ASP.NET, and / or any other similar technology for presenting HTML). A hybrid application can be a hybrid between a native application and a web application. A hybrid application can be a stand-alone, framework, or other similar application container that can load a website in an application container. A hybrid application can be written using a website development tool and / or programming language (e.g., HTML5, CSS, JavaScript, etc.). In an embodiment, a hybrid application uses the browser engine of the analyte sensor computing device 105 instead of using the web browser of the analyte sensor computing device 105 to present the service of the website locally. In some implementations, the hybrid application also accesses computing device capabilities that are not accessible in the web application, such as accelerometers, cameras, local storage, and the like.

[0069] Any combination of one or more computer-usable media or computer-readable media can be used with the embodiments disclosed herein. Computer-usable media or computer-readable media can be, for example, but not limited to, electronic, magnetic, optical, electromagnetic, infrared or semiconductor systems, devices, apparatuses or propagation media. More specific examples of computer-readable media (non-exhaustive list) include the following: electrical connectors with one or more wiring, portable computer floppy disks, hard disks, random access memories (RAM), read-only memories (ROM), erasable programmable read-only memories (EPROM or flash memory), optical fibers, portable compact disk read-only memories (CD-ROMs), optical storage devices, transmission media such as transmission media supporting the Internet or intranet, or magnetic storage devices. Note that the computer-usable media or computer-readable media can even be paper or another suitable medium with a program printed thereon, because the program can be captured electronically, for example, via an optical scan of paper or other media, and then compiled, interpreted or otherwise processed in an appropriate manner as needed, and then stored in a computer memory. In the context of this document, a computer usable medium or computer readable medium may be any medium that can contain, store, convey, propagate or transmit a program for use by or in conjunction with an instruction execution system, device or apparatus. A computer usable medium may include a propagated data signal in baseband or as part of a carrier wave, in which the computer usable program code is embodied. Any suitable medium may be used to transmit the computer usable program code, including but not limited to wireless, wired, optical fiber cable, RF, etc.

[0070] Computer program code for performing operations of the present disclosure may be written in any combination of one or more programming languages, including object-oriented programming languages ​​such as Java, Smalltalk, C++, and conventional procedural programming languages ​​such as the "C" programming language or similar programming languages. The program code may be executed entirely on the user's computing device, partially on the user's computing device as a stand-alone software package, partially on the user's computing device and partially on a remote computer, or entirely on a remote computer or server. In the latter case, the remote computer may be connected to the user's computing device through any type of network including a local area network (LAN) or a wide area network (WAN), or a connection may be made to an external computing device (e.g., via the Internet using an Internet service provider) or a wireless network as described above.

[0071] In addition, the example embodiments may be implemented by hardware, software, firmware, middleware, microcode, hardware description language, or any combination thereof. When implemented in software, firmware, middleware, or microcode, the program code or code segments for performing the necessary tasks may be stored in a machine-readable medium or a computer-readable medium. A code segment may represent a procedure, function, subroutine, program, routine, subroutine, module, program code, software package, class, or any combination of instructions, data structures, program statements, and the like.

[0072] In various embodiments, an article of manufacture may be employed to implement one or more methods as disclosed herein. The article of manufacture may include a computer-readable non-transitory storage medium and a storage medium. The storage medium may include programming instructions configured to cause a device to practice some or all aspects of a method for cross-calibration using a computing device according to an embodiment of the present disclosure.

[0073] The storage medium may represent a wide range of persistent storage media known in the art, including but not limited to flash memory, optical disks, or magnetic disks. In particular, in response to the programming instructions being executed by the device, the programming instructions may enable the device to perform various operations described herein. For example, the storage medium may include programming instructions configured to cause the device to practice using a computing device (e.g., Figure 1 The analyte sensor computing device 105) performs an analyte sensor (e.g., Figure 1 Some or all aspects of the method for calibrating the sensor 107).

[0074] The analyte sensing device 107 may include an analyte sensing element 114. In some examples, the analyte sensing element 114 may include one or more wiring or electrodes for converting the analyte (e.g., glucose) concentration into a representative electrical signal. The analyte sensing device 107 may also include a communication module 108 (e.g., a transmitter, a receiver, or a transceiver) for transmitting data and other information through a network 115 (wired or wireless). In some examples, the analyte sensing device 107 may also include a microprocessor 112 and a printed circuit board 113, similar to that discussed above for the analyte sensor computing device. Other components of the analyte sensing device 107 not shown may include one or more of a memory controller, a volatile memory (e.g., DRAM), a non-volatile memory (e.g., ROM), a flash memory, etc.

[0075] In some embodiments in which the CAM system 100 is configured as a CGM system, in some examples, the system may include an insulin delivery unit 170. The insulin delivery unit 170 may include at least three parts, including but not limited to an insulin pump 171, a line 172, and an infusion device 173. In an embodiment, the insulin pump 171 may be battery-powered and may include (or be fluidly coupled to) an insulin reservoir (e.g., a container), a pumping mechanism (e.g., a pump driven by a small motor), and one or more buttons and / or a touch screen (not shown) to program insulin delivery. In some examples, the insulin pump 171 may receive instructions for insulin delivery from one of the analyte sensor computing device 105 or the analyte sensing device 107 via the network 115. The instructions may be based on the glucose concentration obtained via the analyte sensing device 107. In such an example, it is understood that the insulin delivery unit 170 may operate in a closed-loop manner with other components of the CGM system 100 (e.g., the analyte sensor computing device 105 and the analyte sensing device 107) to mimic the way the pancreas works. It is understood that each of the insulin pump 171, the tubing 172, and the infusion set 173 can be coupled to each other to enable the insulin pump 171 to deliver insulin to the subject through the tubing 172 and the infusion set 173. Although the insulin pump 171 can be battery powered, it is understood that in some additional or alternative examples, the insulin pump 171 can be powered by electrically coupling the insulin pump 171 to an external power source.

[0076] In some examples, the insulin pump 171 may include buttons and / or a touch screen (not shown) for programming insulin delivery parameters. In another additional or alternative example, as mentioned above, the insulin pump 171 may receive instructions for insulin delivery via the network 115. Therefore, in some examples, the insulin pump 171 may include a communication module 173 (e.g., a receiver or transceiver), a printed circuit board 174, and a microprocessor 175 that can receive and / or send information via the network 115 (wired or wirelessly). Other components of the insulin pump 171 not shown may include one or more of a memory controller, a volatile memory (e.g., DRAM), a non-volatile memory (e.g., ROM), a flash memory, etc.

[0077] In some examples, tubing 172 can include a thin tube fluidly coupled to each of the insulin reservoir and the infusion set 173. Tubing 172 can be plastic, Teflon, etc. The infusion set 173 can include component portions made of Teflon and / or steel and can be attached to the skin of the subject via an adhesive patch. The infusion set 173 can include a short thin tube (e.g., a cannula) that is inserted into the skin via a needle contained in the cannula. After insertion, the needle can be removed and the thin cannula can remain under the skin. It will be understood that the above description relates to an example infusion set, but other similar infusion sets can be used interchangeably without departing from the scope of the present disclosure.

[0078] Now turn to Figure 2 , shows a method for cross-calibrating an analyte sensor, such as a CGM sensor (e.g., Figure 1 The present invention provides an example method 200 for a sensor 107 of a subject. The method 200 may be an in vivo method of cross-calibrating a sensor. Specifically, the method 200 may include a computer-implemented method for cross-calibrating a second sensor inserted into the subject tissue based on information / data retrieved from at least a first sensor that has been inserted into the subject tissue and previously calibrated. The method 200 may include software instructions stored on a non-transitory computer-readable medium that, when executed by a processor, cause the processor to execute instructions to cross-calibrate the second sensor.

[0079] Method 200 begins at 210 and includes the initiation of a cross-calibration event. This can be initiated in a variety of ways. For example, a user can activate an event using their CGM device (also referred to herein as an analyte sensor), such as when a new sensor is inserted. In one example, the calibration initiation can be user-initiated (e.g., via an actuator associated with the CGM device), or in another example, the calibration initiation can be automatically recognized by the CGM device (e.g., an actuator actuated upon insertion). Additionally or alternatively, the calibration can be initiated via a user having access to a computing device such as a smart phone (e.g., Figure 1 The analyte sensor computing device 105 of the present invention may be initiated by the computing device 105. In some examples, the computing device may prompt the user to insert a new sensor, and may thereafter initiate calibration of the sensor (automatically upon insertion, based on user confirmation, etc.). For example, such a prompt may be based on a sensor approaching the end of a normal wear period. The end of a normal wear period may include 14 days, however in other examples, the end of a normal wear period may be greater than or less than 14 days (e.g., 30 days) without departing from the scope of the present disclosure.

[0080] In another example, such a prompt may be initiated based on some issue with the performance of the sensor currently being used by the user. For example, in response to an indication of sensor degradation, calibration of the sensor may be initiated. In another example, the calibration initiation event may even be initiated at a predetermined time (e.g., 30 seconds, 1 minute, 5 minutes, 10 minutes, 20 minutes, 30 minutes, 45 minutes, one hour, two hours, etc.) after insertion, rather than immediately upon insertion. As an example, the sensor insertion event may be relayed to the analyte sensor computing device (e.g., Figure 1 The analyte sensor computing device 105 of the embodiment of the present invention may be configured to start a timer associated with the analyte sensor computing device. After a predetermined period of time has passed, the analyte sensor computing device may command the start of a calibration routine.

[0081] In some examples, the time to initiate calibration after sensor insertion can be based on one or more user-specific parameters that have been learned or otherwise inferred over time. For example, although the present disclosure is written with respect to glucose sensors, it is expected that the disclosed methods can be applied to other sensors, such as sensors that track chronic disease conditions, such as sensors that detect creatinine, uric acid, potassium, sodium, urea, and / or various drugs and their metabolites. Other examples include acetylcholine, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase, DNA, fructosamine, glucose, glutamine, growth hormone, hormones, ketones (keytones), lactate / ester, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, troponin, etc. In some examples, the concentration of drugs including but not limited to antibiotics (e.g., gentamicin, vancomycin, etc.), digitoxin, digoxin, drugs of abuse, theophylline, warfarin, etc. can be determined.

[0082] In certain embodiments, a pattern of glucose levels can be established for a user or subject over time so that the system used (e.g., Figure 1 The CGM system 100) learns how the subject's glucose level changes. In an embodiment, these patterns are stored and can be recalled once an individual has been identified through their login information and / or a triggering event. These patterns can then be used to enhance the background correction methods and Figure 2 As an example, the data may be stored in a smart device (e.g., Figure 1 analyte sensor computing device 105), or stored in a cloud or other storage database (e.g., Figure 1 in the database 180).

[0083] In response to the calibration initiation, the method 200 proceeds to 220. At 220, the method 200 includes measuring and recording the current (e.g., one or more current values) from the first analyte sensor within a first determined time period (e.g., 1 minute, 5 minutes, 20 minutes, 30 minutes, 45 minutes, 60 minutes, 2 hours, etc.). It is understood that the first sensor includes a sensor that has been inserted into the subject for a sufficient period of time (e.g., one day, two days, three days, four days, five days, six days, seven days, greater than one day but less than 14 days, greater than 7 days but less than 14 days, greater than 14 days but less than 30 days, etc.) so that the current value from the first sensor is stable and does not drift relative to the actual or true glucose value present in the subject. It is understood that the current value that is stable relative to the actual or true glucose value refers to a current reading and / or a calibrated current reading that is easy to track (e.g., as monitored via a blood glucose tester) the actual blood glucose level. It is further understood that the first sensor has been calibrated before initiating the cross-calibration event that relies on the method 200.

[0084] As an example, the first sensor may have been calibrated, for example, via a blood glucose tester / monitor, using actual blood glucose measurements. As another example, the first sensor may have been calibrated using the Figure 2 The discussed method performs calibration, which is referred to herein as serial cross calibration. Such an example will be described in more detail below.

[0085] The current measurements of the first sensor may be recorded continuously, or may be recorded at discrete time points during a first predetermined time period. For example, depending on the first determined time period, the current measurements may be recorded at intervals of less than one second, one second, two seconds, 5 seconds, 10 seconds, 20 seconds, 30 seconds, one minute, five minutes, etc. In some examples, the current measurements may be averaged over such intervals to generate smooth data samples. It will be appreciated that the first sensor may include a glucose sensor in the case where the calibrated sensor (e.g., the second sensor) also includes a glucose sensor.

[0086] During the same first determined time period, method 200 at step 220 also includes measuring and recording the current value from the second sensor. In some examples, the current measurement value from the second sensor may be recorded at intervals of less than one second, one second, two seconds, 5 seconds, 10 seconds, 20 seconds, 30 seconds, one minute, five minutes, etc., depending on the first determined time period. It will be appreciated that the first determined time period may include a time period that enables the decay trend of the current from the second sensor to be accurately modeled (e.g., modeled as an exponential decay). The modeling may be performed at least in part via a computing device (e.g., a computer) that retrieves the current measurement value from each of the first sensor and the second sensor. Figure 1 This is accomplished by the analyte sensor computing device 105).

[0087] It is understood that once the decay current can be modeled, it may not be necessary to collect additional time points. In other words, the first determined time period may include a variable time period. In some examples, this may take up to 60 minutes to ensure that there is enough information or data to establish a trend and model the trend. This may be driven at least in part by one or more of the rate of change of the signal of the second sensor and the rate of change of the glucose level in the object. For example, if the signal is quickly stabilized and the glucose level of the object does not change very quickly, the first determined time period may be very short. On the other hand, if the stability occurs in a very sharp process, and if the glucose of the person is also changing rapidly, the first determined time period may be extended to one or two hours. As a more specific example, if the glucose level in the object changes very little, only 1 to 3 minutes are needed to establish a trend. On the other hand, if the glucose value changes significantly, 15 to 20 minutes may be required. In some cases, longer time (e.g., 60 minutes to 2 hours) is expected. However, even in the case where the background current changes significantly and the glucose concentration changes rapidly, it is generally expected to take 20 to 30 minutes (rather than longer time). In an embodiment, the second sensor includes a glucose sensor.

[0088] In some examples, to avoid the longer time associated with the first determined time period, it may be desirable to perform the operation under predetermined conditions. Figure 2 Such predetermined conditions may include the time at which the analyte concentration is expected to be stable (e.g., not changing by more than a predetermined threshold value over a predetermined duration). With respect to the case where the analyte is glucose, such conditions may include the case of expected or learned / predicted fasting glucose levels. For example, based on glucose measurements obtained by one or more glucose sensors over time, a trend of glucose concentrations over a specific time period (e.g., days, hours, etc.) may be established. For example, this information may be relied upon to prompt a user to insert a second sensor. In other examples, the user may understand that fasting glucose levels may be expected at specific times (e.g., upon waking up in the morning). These specific times may be preferred for inserting sensors to avoid situations where glucose values ​​change rapidly.

[0089] In response to the current values ​​recorded from each of the first sensor and the second sensor within the first determined time period at step 220, the method 200 proceeds to 230. At 230, the method 200 includes generating a glucose value for the first sensor by relying at least in part on the current measurement value from the first sensor. Although step 230 is depicted as after the recording of the current measurement value of the first sensor is completed, it is understood that in other examples, step 230 can be performed simultaneously when the current measurement value is recorded from the first sensor, provided that sufficient data has been collected to determine the glucose value based on the collected data. More specifically, in some embodiments, the glucose value for the first sensor is generated between 5 seconds and 60 seconds during the first time period. Typically, the first time period lasts between about 1 minute and 60 minutes, but this is determined by the ability of the signal attenuation of the second sensor to be modeled (the sensor to be calibrated).

[0090] Proceeding to 240, method 200 includes predicting or modeling a background current drop of the second sensor as a function of time during a second time period. The second time period may be immediately after the first time period. In some examples, the second time period may have a certain amount of overlap with the first time period. As an example, the background current drop can be predicted based on a model of exponential drop. Specifically, it will be appreciated that the measured current value from the second sensor includes a total current consisting of a non-glucose signal or background current plus any glucose-specific signal. The data generated during the first determined time period (including one or more of the current value recorded from the first sensor, the glucose value generated for the first sensor, and the current value recorded from the second sensor) can enable determination of the rate of change of the non-glucose signal. The background current drop can be modeled to establish a pattern. In some examples, the drop can be modeled as an exponential decay that tends to linear decay at about a specific time (e.g., 5 to 7 hours, 6 hours, 12 hours, etc.) after the initial insertion of the second sensor. In another example, the drop can be modeled by a power function, which is constructed as f(x)=ax . 5 . It will be appreciated that these power functions and exponential functions are not exhaustive, as other models may be used to model specific drops. As discussed above and discussed in further detail below, in some examples, more than one (e.g., 2 or 3) background current drops may be predicted. In such examples, a first background current prediction may include a background current drop that tends to linearly decay at approximately a particular time (e.g., 5 to 7 hours, 6 hours, 12 hours, etc.). For the same type of sensor and the same object, a second background current prediction may be based on historical background current data collected and determined based on one or more previous sensor wear times. This second background prediction may extend to the entire wear time of the second sensor, as described in more detail below.

[0091] Proceed to 250, subtract the predicted current drop of the second sensor as a function of time from the measured current of the second sensor in the second time period (as discussed, it is related to the background or non-glucose driven current). Therefore, at 250, method 200 includes measuring the current, or in other words, continuing to measure the current from the second sensor in the second time period. As mentioned, it is understood that the first time period and the second time period can have a certain degree of overlap. In some embodiments, in the case where historical data from the same object using the same type of sensor can be used to model the background changes (e.g., the second background current) and current sensitivity changes associated with the second sensor, from about the insertion time until about 12 hours after insertion, even up to 7 days after insertion or significantly longer time (e.g., 30 days or more of sensor life) can be subtracted from the measured current of the second sensor. In some embodiments, from about the insertion time until about 12 hours after insertion, the first predicted current drop can be subtracted from the measured current of the second sensor. In some embodiments, from about the insertion time until about 8 hours after insertion, the first predicted current drop can be subtracted. In yet another example, the first predicted current drop can be subtracted from about the time of insertion until about 6 hours after insertion. Other examples of larger or smaller durations of predicted current drops that can be subtracted from the measured current of the second sensor are within the scope of the present disclosure. It will be appreciated that performing the subtraction process as discussed can provide an indication of the contribution of the glucose-specific current change to the measured current of the second sensor.

[0092] In certain embodiments, as discussed, the method further includes predicting a second background current (e.g., a current drop and / or rise) over a third time period beginning at least 12 hours or at least 24 hours after insertion, and applying current predictions from one or more previous sensor wear times that include the third time period to the sensitivity and background current. In certain embodiments, the third time period is between about 1 to 2 days and 30 days after insertion of the second sensor. The second background current can be understood to be predictable based on information or data obtained via the first sensor (or any number of previously worn sensors of the same type for the same subject) that is related to how the second sensor may respond in the subject over time. As an example, there may be a protein coating that begins to affect sensor operation starting on the fifth day of sensor wear time, and the protein coating continues until about the tenth day of sensor wear time for a particular subject. The pattern (e.g., a 25% change in sensor sensitivity) can be learned from the first sensor and / or any number of previously worn sensors for the same subject, can be stored (e.g., in Figure 1at a database 180 of the analyte sensor itself and / or Figure 1 The second background current may be similarly subtracted from the measured current from the second sensor to provide an indication of the contribution of the glucose-specific current change to the measured current of the second sensor. For example, if the second sensor relies on any (e.g., once a day or less) blood glucose calibration, such a process may reduce many subsequent calibrations during the wear time of the second sensor, and / or such a process may be beneficial for any sensor that includes a factory calibration system.

[0093] Proceeding to step 260, method 200 includes creating or generating a conversion operation or algorithm for the second sensor using information from the first sensor (e.g., one or more of the glucose value obtained from the first sensor and the current obtained from the first sensor). In this way, the subtracted current obtained by subtracting the background current or non-glucose current from the measured current from the second sensor can be converted into a second glucose value. In some embodiments, the current value can be smoothed. In an example, the smoothing operation can be a combination of a median filter and a Kalman signal smoothing operation. In some examples, the subtracted current can be scaled to a first current, for example, and the scaled current or calibrated current for the second sensor can be used to develop a conversion operation. However, in other examples, such scaling may not occur, and a conversion operation can be constructed for the subtracted current instead, so that the subtracted current can be easily converted into a second glucose value. Therefore, at step 260, it can be understood that the analyte value has been determined for the first sensor based on the measured current from the first sensor. In addition, the measured current from the second sensor has been subtracted from the background current determined for the second sensor. Thus, at 260, method 200 includes constructing or creating a conversion operation or algorithm that includes a glucose conversion term for the second sensor. Such a conversion operation can be based on one or more of a first current measured from the first sensor, a known glucose value from the first sensor and its relationship to the first current, and a subtracted current determined by subtracting a background current of the second sensor from a current measured by the second sensor, as discussed.

[0094] In embodiments, a model of glucose levels can be constructed from the history of the individual in whom the sensor is inserted (e.g., a pattern of glucose level changes learned over time), and this information can be incorporated into the algorithm. In some examples, the pattern of glucose level changes can be relied upon to predict current and / or future glucose levels, and such information can be incorporated into the algorithm to improve the accuracy and performance of the second sensor. Such information can be stored in a database (e.g., Figure 1 database 180). As a representative example, if a motion artifact occurs while the subject is wearing the second sensor, and such a motion artifact has been so determined based on historical data, the motion artifact can be flagged upon detection, which can prompt a request to check the blood glucose value before acting on the glucose reading (e.g., before providing instructions to the subject or the insulin delivery system regarding the amount of insulin to be administered). In other words, it can be learned (e.g., machine learning, deep learning) based on historical data that the subject's blood glucose is not expected to change as quickly or as much as, for example, the current change caused at the second sensor due to a particular motion artifact. By identifying motion-induced artifacts prior to acting on a glucose reading originating from the current caused by the motion artifact at the second sensor, instructions that are not relevant to the current biological state can be avoided.

[0095] Furthermore, at least some degree (e.g., daily variation) of the initial measured current from the second sensor may be related to a biological process beneath the skin that is standard for the individual. While such a process may vary significantly between different individuals, it is likely that the process is fairly consistent for a particular individual. Thus, in some examples, the initial measured current from the second sensor may be, for example, in a database (e.g., Figure 1 The established or learned change patterns (e.g., predictable changes associated with changes in the second sensor current with respect to the background signal) can be stored in a database 180 of the analyte sensor computing device (e.g., Figure 1The established pattern of the initial first day change for the individual is accessed from the profile on the analyte sensor computing device 105 of the device. Other components of non-glucose related signals can be based on modeling related to the rate of change of non-glucose signals during the time when two sensors generate data simultaneously. In an embodiment, a part of the calibration can be based on the signal establishment conversion factor for the signal change, such as the current value not caused by the change of glucose is removed or not modeled after the signal is retained. In some examples, the conversion factor can include a certain degree of individual modeling based on the deposition rate of determined proteins outside the sensor and how this changes the response of the sensor to the glucose in contact with it. In some examples, such information can be specific to the individual and can be similarly stored in a database or otherwise associated with a user profile so that the information can be incorporated into the modeling (e.g., at least partially for establishing a conversion factor). The conversion factor can also additionally or alternatively include a historical factor based on the characteristics of a specific individual of, for example, daily glucose offset distribution, daily sensitivity and background current average or activity level observed on the same individual with a second sensor. The calibration can be used to convert the net current generated at the second sensor surface into a blood glucose equivalent glucose value. Thus, as discussed herein, it is understood that the sensor inserted into the skin measures interstitial glucose levels, but the cross-calibration method used links the interstitial measurement to a blood glucose calibration (e.g., at least the first sensor is calibrated based on a blood glucose sample obtained from a blood glucose tester). Thus, the analyte value measured by the sensor placed in the interstitium (also referred to herein as a glucose value) can be understood to include an interstitial value corresponding to a blood equivalent value (e.g., a blood equivalent glucose value).

[0096] Based on the conversion operation developed at 260, at step 270, a glucose value is generated for the second sensor. In an embodiment, the conversion of the current value from the sensor to the glucose value may involve several steps, such as several signal processing steps. In an embodiment, a spike detection step may be relied upon to look for spikes in the current data that may be associated with motion artifacts. If these are detected, the data may not be used to create a new glucose value because they can be removed from the calculation. After removing the spike artifacts, the smoothed current value may be filtered to create the best quality signal possible. The filtering step may include passing through one or more of a median filter, a Kalman filter, or other related filters. The generated glucose value may, for example, be displayed in an analyte sensor computing device (e.g., Figure 1 analyte sensor computing device 105), exported to a database (e.g., Figure 1 database 180) and / or transmitted to one or more other networked devices (e.g., Figure 1 Then, the method 200 may end.

[0097] Understandably, Figure 2 The cross-calibration method can achieve serial cross-calibration of multiple sensors over time. Specifically, as an example, at the time of insertion, only the first sensor may have to be calibrated by external means including but not limited to actual blood glucose measurements (e.g., via a blood glucose tester). Then, after this initial calibration process, any number of subsequent sensor insertion events may depend on Figure 2 The invention provides a cross-calibration method for the tester, thereby alleviating the need for the subject to have to perform a calibration routine involving obtaining actual blood glucose measurements. This may improve customer / user satisfaction and reduce the chance of infection or other adverse biological responses associated with the reuse of glucose testers. In addition, the overall cost may be reduced because the reliance on actual blood glucose test results may be reduced or substantially avoided after the first sensor is calibrated. As a specific example, after calibrating the first sensor via the use of actual blood glucose measurements, when the second sensor is inserted some time later, the calibration may be performed using the actual blood glucose measurements. Figure 2 The first sensor can then be removed from the subject and the second sensor can be relied upon for blood glucose determinations. After another period of time, a third sensor can be inserted into the subject and, again, the second sensor can be used. Figure 2 The cross-calibration process of the present invention can be used to calibrate the third sensor based on the second sensor. The second sensor can then be removed and the third sensor can be relied upon for blood glucose determination. As mentioned above, this process can be repeated any number of times.

[0098] In order to improve the accuracy of blood glucose determination based on the cross-calibration method, it may be desirable to confirm that the cross-calibration method has been successful (e.g., the second sensor is calibrated to the expected or desired level of accuracy or sensitivity). As discussed herein, sensitivity can be understood to be related to the ratio of current to analyte concentration. For example, it may be desirable to ensure that after the cross-calibration process, the second sensor that has been recently calibrated exhibits expected behavior consistent with the previous glucose determination / sensitivity of the first sensor used in the cross-calibration process in terms of glucose determination and sensitivity. In addition, before the subject removes the first sensor, it may be desirable to ensure that the second sensor operates as expected or expected. For example, in the case where the first sensor works as expected but the second sensor does not work as expected for some reason, it may be advantageous to continue to rely on the first sensor for glucose determination until another sensor can be properly calibrated for use.

[0099] Therefore, now turn to Figure 3 , showing the method for determining the Figure 2An example method 300 is provided for determining whether a cross-calibration process performed by a method of the present invention has resulted in a newly inserted sensor being properly calibrated (e.g., according to an expected or desired calibration). The method 300 may include a computer-implemented method and may include software instructions stored on a non-transitory computer-readable medium that, when executed by a processor, causes the processor to perform the instructions set forth by the steps of the method 300.

[0100] The method 300 begins at 310 and includes performing the calibration procedure described above for a second sensor that has been inserted into an object into which a previously calibrated first sensor has been inserted. Figure 2 The cross calibration process discussed. After the cross calibration, method 300 proceeds to 315. At 315, method 300 includes obtaining a glucose concentration determination from each of the first sensor and the second sensor. Step 315 may include obtaining one or more glucose determinations from each of the first sensor and the second sensor. As an example, multiple glucose determinations can be obtained for each of the first sensor and the second sensor within a predetermined time period after the cross calibration process (or even at a certain moment during the cross calibration process). In some examples, three different measurements for each of the first sensor and the second sensor can be obtained within a predetermined time period (e.g., 30 seconds, 1 minute, 2 minutes, 5 minutes, etc.). In other examples, any number of measurements greater than three can be obtained within a predetermined time period.

[0101] In the case where a glucose concentration determination is obtained for each of the first sensor and the second sensor, the method 300 proceeds to 320. At 320, the method 300 includes comparing the glucose concentration determinations. As an example, a fitting process (e.g., linear fitting, least squares method, etc.) can be performed on the data obtained for each sensor to establish a trend line for each of the sensors. This can enable a first trend and a second trend to be established for each of the first sensor and the second sensor. The fits of each set of data can then be compared to determine whether the second sensor is producing a glucose concentration determination that is consistent or correlated with the glucose concentration determination obtained via the first sensor. If the trend of the second sensor does not overlap with the trend of the first sensor within a predetermined threshold range, it can be indicated that the glucose concentration determination made via the second sensor is not correlated with the glucose concentration determination made via the first sensor. Alternatively, if the trend of the second sensor is consistent with the trend of the first sensor within a predetermined threshold range, it can be indicated that the glucose concentration determination made via the second sensor is correlated with the glucose concentration determination made via the first sensor.

[0102] Thus, in response to an indication that the second sensor glucose concentration determination is consistent with or correlated with the glucose concentration determination made via the first sensor, method 300 proceeds to 330. At 330, method 300 includes providing an indication that the first sensor may be removed. As an example, the second sensor may be removed via an analyte sensor computing device (e.g., Figure 1 Such an indication may be provided digitally on a display screen associated with the analyte sensor computing device 105 of the present invention. Additionally or alternatively, the indication may be provided via an audible alarm, which in some examples may originate from the analyte sensor computing device or the first sensor itself. Additionally or alternatively, some other means (e.g., a visual alarm, such as an LED or other light-based alarm) may be used to convey to the user that the first sensor may be removed. For example, the alarm may include a text-based message, an email, etc., sent to an application on the user's phone.

[0103] Proceeding to 335, method 300 includes providing instructions for insulin injection based on the second sensor glucose determination over time until another sensor is inserted into the subject. It will be appreciated that in some examples where the glucose determination is not associated with an open-loop or closed-loop insulin injection step, this step may be optional. For example, in some examples, a user may desire to monitor glucose levels over time without performing an insulin injection step based on the data obtained. However, in other examples where an insulin injection step occurs based on the glucose determination, step 335 may be included. As an example, the instructions provided at 335 may include instructions for a user to, for example, perform an insulin injection via communication with an analyte sensor computing device (e.g., Figure 1 If only instructions for viewing by the user are provided, it can be understood that insulin injection involves an open-loop insulin injection method because it is performed by the user via the insulin injection process provided by the instructions.

[0104] Alternatively, the instructions provided at 335 may include instructions sent to an insulin delivery unit (e.g., Figure 1 Such an example may be understood to include a closed-loop insulin injection method. Specifically, based on the determined glucose concentration, appropriate instructions may be provided to the insulin delivery unit so that a determined amount of insulin is automatically injected without user input.

[0105] It will be appreciated that method 300 may terminate in response to an indication that the first sensor may be removed and / or in response to the second sensor being used to provide a glucose concentration determination (which in some examples may additionally include providing instructions related to insulin injection in dependence upon such concentration determination).

[0106] Returning to 325, in examples where the glucose concentration determination for the second sensor does not indicate consistency or correlation with the glucose determination obtained via the first sensor, method 300 may continue until the concentrations are indicated to be correlated within a predetermined threshold range at 325. As depicted, in some examples, continuing method 300 may further include performing Figure 3 Repeat before the method Figure 2 cross-calibration process. However, in other examples, the same cross-calibration may be used and additional glucose concentrations may be determined only for each of the first sensor and the second sensor so that the comparison at step 320 may be repeated. Once an indication is given at 325 that the concentrations are correlated within a predetermined threshold range, the method may proceed to 330 as discussed above. Although not explicitly shown, in some examples where a positive result is not returned at step 325 after a predetermined number of attempts, mitigating action may be taken to calibrate the second sensor in an additional or alternative manner. As one example, the method may include a request to calibrate the second sensor based on one or more blood glucose test measurements. As another example, the method may include a request to calibrate the first sensor based on such one or more blood glucose test measurements to ensure that the first sensor is operating as desired or expected. Once it has been confirmed that the first sensor is operating as desired or expected, at step 325, a request may again be made to calibrate the second sensor based on the one or more blood glucose test measurements. Figure 3 The method determines when the second sensor is effectively calibrated.

[0107] Now turn to Figure 4 , shows a prophetic example timeline 400 showing how to proceed Figure 2 Cross calibration method. Figure 4 All of the curves in are depicted with respect to time (x-axis) and, therefore, can be understood to occur as a function of time. Timeline 400 includes curve 405, indicating the raw current recorded from the first sensor over time. In this example timeline, it can be understood that the first sensor has been implanted in the subject for approximately 12 days, however, in other examples, longer times (e.g., up to 30 days) are expected. Timeline 400 also includes curve 410, indicating the glucose concentration over time determined by converting the raw current from the first sensor (curve 405) into a glucose value. Timeline 400 also includes curve 415, indicating the raw current recorded from the second sensor over time. It can be understood that for this example timeline, the second sensor has been inserted into the subject at approximately time t0. Timeline 400 also includes curve 420, indicating the predicted background current associated with the second sensor over time. Line 422 represents the first duration (reference time t0). Figure 2 220 in step 220), and line 424 represents the second duration (refer to Figure 24. Step 250 in step 250). Timeline 400 also includes curve 430, indicating a subtracted second sensor current obtained by subtracting a predicted background current (curve 420) from an original second sensor current (curve 415) over time. Timeline 400 also includes curve 440, indicating a glucose concentration measured by the second sensor over time, the glucose concentration being determined via converting the subtracted second sensor current (curve 430) into a glucose value. Timeline 400 also includes curve 445, representing a glucose value that might have been obtained from the second sensor if the cross-calibration process had not been performed. Timeline 400 also includes curve 450 overlapping with curve 455, indicating the same glucose value as curve 440 (the glucose value obtained from the cross-calibrated second sensor), which indicates the same glucose value as curve 405 (the glucose value obtained from the first sensor, where the first sensor had been previously calibrated before time t0).

[0108] At time t0, the cross calibration process is initiated. The time frame spanning time t0 and t1 in this example timeline 400 includes a first duration. During the first duration, currents from the first sensor (curve 405) and the second sensor (curve 415) are measured. In addition, based on the current recorded from the first sensor, a glucose value is obtained for the first sensor (reference curve 410).

[0109] The first duration includes a variable duration, which can be understood as being based on the ability to model or predict the background current. In this example timeline, the glucose value does not change significantly during the first duration (see curve 410), and it can therefore be understood that the time between time t0 and t1 represents only a few minutes. Specifically, as mentioned above, due to the ability to easily model the decaying current associated with the second sensor, the first duration can be shorter when the glucose level does not change rapidly. At time t1, the background current (curve 420) is predicted based at least in part on the decay of the raw current (curve 415) of the first sensor during the first duration. It can be understood that the prediction of the background current can take into account other factors, including but not limited to one or more of the following: the raw current measured via the first sensor (curve 405), the glucose value obtained from the first sensor (see curve 410), and, for example, from a database (e.g., Figure 1 Historical data retrieved from a database 180 of a sensor worn by the same subject) or other data storage device storing data previously obtained from sensors worn by the same subject. In some examples, the pattern of background current decay can be learned over time (e.g., via a machine learning algorithm or a deep learning algorithm), and the pattern can be called or retrieved to assist in predicting background current. As depicted, the background current is predicted over a second duration (line 424) that extends beyond the first duration.

[0110] Between time t0 and t1, the glucose level in the subject remains relatively stable (reference curve 410), and therefore the raw current (curve 415) from the second sensor approximately tracks the predicted background current (curve 420). At time t2, the glucose level in the subject begins to change (curve 410). Therefore, the measured current (curve 415) from the second sensor deviates from the predicted background current (curve 420). During the second duration, the predicted background current (curve 420) is subtracted from the second sensor current (curve 415) to produce a subtracted second sensor current (curve 430). Based on one or more of the measured current (curve 405) from the first sensor, the glucose value (curve 410) obtained from the first sensor, and the subtracted sensor current (curve 430), a conversion operation or algorithm for producing a glucose value for the second sensor is generated. Based on the conversion algorithm, a second sensor glucose value (curve 440) is obtained. As a reference, curve 445 shows a second sensor glucose value that may have been obtained if the second sensor is not subjected to a cross-calibration process. Specifically, as the background current changes (e.g., decays) over time, the second sensor may be inaccurate if the glucose value is inferred by relying on the original current rather than relying on the subtracted second sensor current. Curve 450 represents the same glucose value as curve 440, and curve 455 represents the same glucose value as curve 405 to illustrate that the cross-calibration method enables the second sensor to accurately report glucose values ​​similarly to the first sensor. Once it is established that the second sensor is operating as expected or desired, the first sensor can be removed. For example, as described above with respect to Figure 3 As discussed in the method of and in particular with respect to step 325 of method 300, the glucose value determined via the first sensor may be compared to the glucose value determined via the second sensor, and in response to an indication that the values ​​are correlated within a predetermined threshold range, an indication may be given that the first sensor may be removed. In the event that the glucose value determined via the first sensor is not indicated as being correlated with the glucose value determined via the second sensor, then the method may continue to loop as discussed above until an affirmative response (e.g., yes) is returned at step 325 of method 300, enabling the subject to remove the first sensor.

[0111] Although in Figure 4It is not explicitly shown in, but it is understood that in some examples, the second background current can be obtained, for example, at a predetermined time since the insertion of the second sensor (e.g., 12 to 24 hours after the second sensor is inserted). The second background current can be modeled based on data retrieved from any number of other previously worn sensors (which may include the first sensor), provided that the other previously worn sensors are of the same type as the second sensor and the objects between the previously worn sensors and the second sensor are the same. The second background current can be modeled for the entire wearing time of the second sensor. For example, the second background current can be modeled for 15 days or longer, 20 days or longer, or 25 days or longer, or 30 days or longer. By modeling the second background current for such a length of time after the insertion of the second sensor, the subtraction operation can continue to be performed on the current measured by the second sensor within the life of the second sensor. This can, for example, improve the accuracy of the second sensor with respect to the conversion of the subtracted current obtained from the second sensor to the second sensor glucose value.

[0112] It is understood that the first background current can be subtracted during the first duration, and the second background current can be subtracted during the second duration. Each of the first duration and the second duration can be variable. For example, as discussed, a conversion operation including one or more conversion parameters can be established or generated, which can be used to convert the subtracted current into the second sensor glucose value during each of the first duration and the second duration. During the first duration, in response to the conversion operation effectively and accurately converting the subtracted current into an indication of the second sensor glucose value, the first duration can end. Similarly, during the second duration, in response to the conversion operation effectively and accurately converting the subtracted current into an indication of the second sensor glucose value, the second duration can end. In other words, the first duration and the second duration may not include a predetermined duration, but the disclosed processing corresponding to each of the first duration and the second duration can end when they are no longer needed. It is understood that when the conversion parameters for the second sensor and the background correction for the second sensor have been correctly established, it is no longer necessary to continue the processing. In some examples, one or more conversion parameters used during the first duration and the second duration can be the same, however, it is understood that one or more conversion parameters can be different without departing from the scope of the present disclosure.

[0113] In addition, although Figure 4It is not explicitly shown in, but it is understood that in some examples, the determination of the second sensor glucose value can be based at least in part on an analyte sensitivity value determined as a function of time for a previously worn sensor (e.g., any number of previously worn sensors, provided that the sensor is of the same type as the second sensor and is worn by the same subject as the second sensor). The analyte sensitivity value can be related to a biological process that occurs in the subject over time in response to a new sensor (e.g., an inserted second sensor). As an example, such a biological process can include a protein coating of the newly inserted sensor. For a newly introduced sensor, such a process may be very similar as a function of time, and a conversion factor can be determined so that the learned analyte sensitivity changes that reliably occur in a particular subject over time can be applied to the newly introduced sensor. In this way, the sensitivity of the newly introduced sensor can be improved during the time that the newly introduced sensor is worn by the subject (e.g., over the entire life of the sensor).

[0114] In this way, the accuracy and sensitivity of a newly inserted analyte sensor can be improved, particularly during periods of time when accuracy and sensitivity are reduced due to problems associated with varying background currents. By using the cross-calibration methods discussed herein, a newly inserted sensor can be easily calibrated based on another sensor that has already been inserted subcutaneously into a subject, thereby avoiding calibration methods that rely on actual blood measurements.

[0115] Example

[0116] Example 1

[0117] Comparison of the cross-calibration method with the calibration method that relies on actual blood glucose test measurements

[0118] This example shows that, compared with calibration methods that rely on actual blood glucose test measurements, as described in this paper Figure 2 The cross calibration method discussed herein is superior in calibrating CGM sensors.

[0119] Steering Figure 5 , depicts the method used to test the Figure 2500 of an example experimental process of the cross-calibration method discussed in . Briefly, the process includes inserting a first CGM sensor (#BO) into a subject on day 1. The first CGM sensor (#BO) is inserted 6 days before the insertion of a second CGM sensor (#G4) and a third CGM sensor (#H13). Prior to inserting the second and third sensors on day 7, the first CGM sensor (#BO) is calibrated using blood glucose values ​​obtained via a blood glucose meter during the period when the first CGM sensor (#BO) was worn. After the second and third sensors (#G4) are inserted, the first CGM sensor (#B0) is calibrated using the blood glucose values ​​obtained via a blood glucose meter during the period when the first CGM sensor (#B0) was worn. Figure 2 The cross-calibration method described in calibrates each of the second sensor and the third sensor. Specifically, each of the second sensor (#G4) and the third sensor (#H13) is cross-calibrated depending on the first sensor (#BO). Figure 5 The experimental procedure described in Figures 6 to 8 Depicted in.

[0120] Specifically, Figure 6 6 is a graph 600 showing CGM measurements 605 converted to glucose concentration (mM) for a first CGM sensor (#BO) and a plurality of actual blood glucose measurements 610 obtained via a blood glucose tester. As mentioned above, the first sensor is calibrated based on the actual blood glucose measurements, and a selected number of actual blood glucose measurements 610 are shown to show the accuracy of the calibration of the first sensor (#BO).

[0121] Figure 7 7 is a graph 700 showing CGM measurements 705 converted into glucose concentration (mM) for a second CGM sensor (#G4). Figure 2 The method is relative to the first CGM sensor (#BO) Figure 7 Perform cross calibration on the second CGM sensor in the Figure 7 Also shown in FIG. 7 are a plurality of actual blood glucose measurements 710 obtained via a blood glucose tester. It is understood that the actual blood glucose measurements 710 are not used in any way to calibrate the second CGM sensor (#G4), but are shown to illustrate the accuracy of the cross-calibration method for calibrating the second CGM sensor. It is also understood that Figure 7 Time 0 (minutes) in represents the time when the second CGM sensor is inserted into the subject.

[0122] Figure 8 8 is a graph 800 showing CGM measurements 805 converted into glucose concentration (mM) for a third CGM sensor (#H13). Figure 2 The method is relative to the first CGM sensor (#BO) Figure 8Perform cross calibration on the third CGM sensor in the Figure 8 Also shown in FIG. 8 are a plurality of actual blood glucose measurements 810 obtained via a blood glucose tester. It is understood that the actual blood glucose measurements 810 are not used in any way to calibrate the third CGM sensor (#H13), but are shown to illustrate the accuracy of the cross-calibration method for calibrating the third CGM sensor. It is also understood that Figure 8 Time 0 (minutes) in represents the time when the third CGM sensor was inserted into the subject.

[0123] about Figures 7 and 8 As part of the cross-calibration process for each of the second sensor (#G4) and the third sensor (#H13), it will be appreciated that Figure 2 The method uses current data and calibrated glucose levels obtained from the first CGM sensor (#BO).

[0124] Table 1 shows the accuracy results of the cross-calibration process used to calibrate the second CGM sensor (#G4) and the third CGM sensor (#H13) compared to the calibration process for the first CGM sensor (#BO) that relied on actual blood glucose test readings.

[0125]

[0126] The results depicted in Table 1 show that when sensor #H13 was cross-calibrated, the total error in readings (expressed as MARD) was 14.3% on Day 1 and 11.4% on the remaining six days (where Day 1 refers to the day the third CGM sensor (#H13) was inserted into the subject). When the same error calculation was performed on the second CGM sensor (#G4), the error was 10.6% on Day 1 and 6.1% on the remaining six days. The last column represents the results when blood glucose values ​​were used to calibrate the CGM sensor response. These results show that the cross-calibration method disclosed herein produces results that are superior to other calibration methods that rely on actual blood glucose measurements. Specifically, calibration that relies on actual blood glucose measurements will produce results of 16.0% for sensor #H13 and 15.7% for sensor #G4. This analysis demonstrates the advantages of the cross-calibration method as discussed herein. First, this example shows that the cross-calibration method provides a better estimate of NGC, thereby producing much better performance than a calibration process that relies on actual blood glucose test measurements. Second, this example shows that using multiple glucose values ​​that are close together can provide a better calibration process than multiple values ​​spread out over 7 days.

[0127] Example 2

[0128] Comparison between the original uncalibrated current trace and the CGM sensor calibrated via the cross-calibration method and the actual blood glucose measurement

[0129] This example shows that the background current signal for a CGM sensor starts high after insertion and gradually decreases exponentially, and by using the cross-calibration method, an accurate glucose reading can be produced immediately after the sensor is inserted into a subject. Specifically, Fig. 9A 9 is a graph 900 showing an example of a raw uncalibrated current (nA) 905 from a CGM sensor inserted into a subject over time. The time reflects the minutes after sensor insertion and shows how the current continues to drop over a time range of about 6 to 12 hours. As a reference, an actual blood glucose value 906 obtained from the same subject with a CGM sensor inserted is also depicted. The difference between the raw current and the actual blood glucose shows the need to correct for background signals or non-glucose signals that drive the offset seen in the raw current trace 905.

[0130] Steering Fig. 9B , depicts a graph 950 showing the Fig. 9A An example of determining glucose concentration as a function of time for a CGM sensor inserted into a subject discussed in . Specifically, line 955 depicts the glucose concentration determined via Fig. 9A , and point 956 represents the actual blood glucose measurement obtained via the blood glucose tester. The CGM sensor is calibrated via the cross calibration method when inserted. This example shows that the cross calibration produces a glucose measurement that is very close to the actual glucose measurement determined via the blood glucose tester. In other words, this example shows that the cross calibration method discussed herein corrects the raw current trace ( Fig. 9A The line 905 in the figure is related to the actual blood glucose value ( Fig. 9A Point 906 and Fig. 9B 956) to generate a CGM-based blood glucose determination (reference Fig. 9B 955), the CGM-based blood glucose determination accurately reflects the actual blood glucose determination determined by the test meter ( Fig. 9B Curve 956 in FIG. 1 ). It can be understood that Fig. 9B The example graph in Fig. 9A The data depicted in .

[0131] For example, the present disclosure may also include the following technical solutions:

[0132] Solution 1. A method for biosensor calibration, the method comprising:

[0133] measuring a first current from a first biosensor and measuring a second current from a second biosensor for a first duration, the first biosensor having been inserted into tissue of a subject prior to inserting the second biosensor;

[0134] converting the first current into a first analyte value;

[0135] comparing the first current to the second current; and

[0136] A second analyte value is generated for the second biosensor based on the comparison, thereby calibrating the second biosensor.

[0137] Option 2. The method of Option 1, wherein the first biosensor is inserted into the tissue of the subject at least one day but less than thirty days before the insertion of the second biosensor.

[0138] Option 3. The method according to Option 1 further includes calibrating the first biosensor before initiating calibration of the second biosensor; and

[0139] Wherein, the first biosensor is calibrated based on one or more blood analyte values ​​obtained from the subject's blood.

[0140] Option 4. The method of Option 1, wherein the first duration is at least one minute and no more than sixty minutes; and

[0141] wherein converting the first current into the first analyte value occurs between five seconds and sixty seconds from the start of the first duration.

[0142] Embodiment 5. The method of embodiment 1, wherein comparing the first current with the second current and generating the second analyte value further comprises:

[0143] predicting a first background current over a second duration, the first background current being a portion of the second current as a function of time, the second duration extending beyond the first duration, and wherein the second current continues to be measured during the second duration;

[0144] subtracting the first background current from the second current measured during the second duration to obtain a subtracted second current; and

[0145] Based at least in part on one or more of the first current and the first analyte value, a conversion process is constructed, the conversion process then used to generate the second analyte value for the second biosensor.

[0146] Option 6. A method according to Option 5, wherein the first background current is predicted based at least in part on one or more of the second current, the first current, and the first analyte value.

[0147] Option 7. A method according to Option 5, wherein the second duration is extended to twelve hours after insertion of the second biosensor.

[0148] Embodiment 8. The method of embodiment 5, wherein comparing the first current with the second current and generating the second analyte value further comprises:

[0149] predicting a second background current over a third duration, the second background current being a portion of the second current as a function of time, the third duration extending beyond the first duration and the second duration, and wherein the second current continues to be measured during the third duration;

[0150] subtracting the second background current from the second current measured during the third duration to obtain the subtracted second current; and

[0151] The second analyte value is generated for the second biosensor using the conversion process based on the subtracted second current determined during the third duration as an input.

[0152] Embodiment 9. The method of embodiment 8 further comprises retrieving historical data related to analyte sensitivity for one or more other biosensors previously worn by the subject; and

[0153] A correction factor derived from the analyte sensitivity is applied in generating the second analyte value to increase the sensitivity of the second biosensor.

[0154] Option 10. The method according to Option 1, wherein each of the first biosensor and the second biosensor comprises a glucose biosensor; and

[0155] Wherein the first analyte value and the second analyte value each correspond to one or more glucose values.

[0156] Embodiment 11. A system for delivering insulin to a subject in need thereof, the system comprising:

[0157] The first glucose biosensor;

[0158] a second glucose biosensor;

[0159] A mobile computing device comprising a processor having instructions stored in a non-transitory memory, the instructions when executed causing the processor to:

[0160] receiving an indication that the second glucose biosensor has been inserted into the subject, if the first glucose biosensor has been inserted into the subject;

[0161] initiating a cross-calibration process within a determined amount of time after receiving said indication;

[0162] obtaining a first current from the first glucose biosensor and a second current from the second glucose biosensor;

[0163] converting the first current into a first glucose value;

[0164] predicting a background current associated with the second glucose biosensor based at least in part on the first current, the second current, and the first glucose value;

[0165] subtracting the background current from the second current to obtain a subtracted second current;

[0166] creating a conversion operation for converting the subtracted second current into a second glucose value, the conversion operation being based at least in part on one or more of the first current and the first glucose value;

[0167] converting the subtracted second current into the second glucose value based on the converting operation; and

[0168] A set of instructions is provided related to delivering insulin to the subject based on the second glucose value.

[0169] Solution 12. The system according to solution 11, further comprising:

[0170] an insulin delivery unit in communication with the mobile computing device, the insulin delivery unit comprising at least an insulin pump and an infusion set, the infusion set fluidly coupled to the insulin pump via tubing; and

[0171] Wherein the processor of the mobile computing device stores further instructions to send the set of instructions to the insulin delivery unit for delivering insulin to the subject via the infusion set by controlling the operation of the insulin pump.

[0172] Solution 13. The system according to Solution 11, wherein the mobile computing device further comprises:

[0173] Display; and

[0174] Wherein the processor of the mobile computing device stores additional instructions to transmit, via the display, the set of instructions related to delivering insulin to the subject.

[0175] Option 14. The system of Option 11, wherein the processor of the mobile computing device stores further instructions to:

[0176] comparing the first glucose value to the second glucose value; and

[0177] In response to an indication that the second glucose value correlates within a predetermined threshold of the first glucose value, providing the set of instructions related to delivering insulin to the subject based on the second glucose value.

[0178] Option 15. The system of Option 14, wherein the processor of the mobile computing device stores further instructions to:

[0179] Responsive to an indication that the second glucose value correlates within the predetermined threshold of the first glucose value, an alert is provided to the subject that the first glucose biosensor can be removed.

[0180] Option 16. The system of Option 11, wherein the processor of the mobile computing device stores further instructions to:

[0181] predicting the background current between one minute and 60 minutes after initiating the cross-calibration process; and

[0182] The background current is subtracted from the second current up to two days after initiating the cross-calibration process, and the subtracted second current is converted to the second glucose value based on the conversion operation.

[0183] Embodiment 17. A device for calibrating a biosensor inserted into tissue of a subject, the device comprising:

[0184] A mobile computing device comprising a processor having instructions stored in a non-transitory memory, the instructions when executed causing the processor to:

[0185] detecting insertion of a second sensor into the tissue in the presence of a first sensor inserted into the tissue of the subject;

[0186] In response to the detecting, initiating a cross-calibration process of the second sensor;

[0187] obtaining a first current from the first sensor and a second current from the second sensor, and converting the first current into a first analyte value;

[0188] responsive to an indication that a predetermined condition for modeling a first non-glucose driven background current associated with the second sensor is satisfied, predicting the first non-glucose driven background current for the second sensor for a first duration;

[0189] subtracting the first non-glucose driven background current from the second current during the first duration to obtain a subtracted second current for the second sensor; and

[0190] The subtracted second current is converted into a second analyte value.

[0191] Option 18. A device according to Option 17, wherein the processor stores additional instructions to predict the first non-glucose driven background current based on the second current measured before the predetermined condition is met and at least partially based on one or more of the first current and the first analyte value obtained before the predetermined condition is met.

[0192] Option 19. A device according to Option 18, wherein the processor stores additional instructions to predict the first non-glucose driven background current based on previously generated patterns of background current changes over time learned from multiple other analyte sensors inserted into the subject at an earlier time.

[0193] Embodiment 20. The apparatus of embodiment 17, wherein an indication that a predetermined condition for modeling the first non-glucose driven background current is satisfied occurs between one minute and sixty minutes after initiating the cross-calibration process; and

[0194] wherein the first duration of time during which the first non-glucose driven background current is subtracted from the second current is at least two hours and up to sixty-four hours.

[0195] Embodiment 21. The apparatus of embodiment 17, wherein the processor stores further instructions to model a second non-glucose driven background current associated with the second sensor for a second duration extending beyond the first duration;

[0196] continuing to obtain the second current from the second sensor during the second duration;

[0197] subtracting the second non-glucose driven background current from the second current measured during the second duration to obtain the subtracted second current for the second sensor; and

[0198] The subtracted second current is converted into the second analyte value.

[0199] Option 22. An apparatus according to Option 21, wherein the second duration of time in which the second non-glucose driven background current is subtracted from the second current is at least 15 days and up to 32 days.

[0200] Option 23. A device according to Option 21, wherein the processor stores additional instructions to model the second non-glucose driven background current based on data retrieved from one or more analyte sensors previously worn by the subject and of the same type as each of the first sensor and the second sensor.

[0201] Embodiment 24. The apparatus of embodiment 21, wherein obtaining the subtracted second current and converting the subtracted second current into the second analyte value further comprises:

[0202] recalling, via further instructions stored in the non-transitory memory of the processor, one or more previously learned analyte sensitivity values ​​from previous use of other analyte sensors by the subject; and

[0203] A calibration process is applied to obtain accurate analyte sensitivity for the second sensor.

[0204] Embodiment 25. The apparatus of embodiment 21, wherein the processor stores additional instructions to generate a conversion operation, the conversion operation comprising one or more conversion parameters and for converting the subtracted second current into the second analyte value during each of the first duration and the second duration;

[0205] wherein each of the first duration and the second duration is variable, and each of the first duration and the second duration is terminated in response to an indication that the converting operation accurately converted the subtracted second current to the second analyte value during each of the first duration and the second duration; and

[0206] The one or more conversion parameters for the conversion operation are the same or different between the first duration and the second duration.

[0207] Embodiment 26. A non-transitory computer-readable storage medium having stored thereon an executable program for biosensor calibration, wherein the executable program instructs a microprocessor to perform the following steps:

[0208] detecting that a second analyte sensor has been inserted into the skin of the subject after inserting a first analyte sensor into the skin of the subject, wherein the insertion of the first analyte sensor occurred between one day and thirty days before the insertion of the second analyte sensor;

[0209] initiating a cross-calibration process based on the detection;

[0210] retrieving a first current from the first analyte sensor and a second current from the second analyte sensor, and converting the first current to a first analyte value within five seconds to sixty seconds of initiating the cross-calibration process;

[0211] determining, within sixty seconds to one hour after initiating the cross-calibration procedure, that a current decay trend can be established for the second analyte sensor based on the second current, and in response, predicting an extrapolated background current over a duration based at least in part on the second current measured within sixty seconds to one hour after initiating the cross-calibration procedure;

[0212] subtracting the background current distribution from the second current to obtain a subtracted second current during the duration; and

[0213] The subtracted second current is converted into a second analyte value, thereby calibrating the second analyte sensor.

[0214] Embodiment 27. The non-transitory computer-readable storage medium of embodiment 26, wherein the executable program stores additional instructions to:

[0215] during the duration, continuing to convert the first current into the first analyte value;

[0216] comparing the first analyte value to the second analyte value during the duration; and

[0217] Responsive to the first analyte value obtained during the duration correlating within a predetermined threshold of the second analyte value, it is determined that the second analyte sensor is effectively calibrated and the first analyte sensor can be removed.

[0218] Embodiment 28. The non-transitory computer-readable storage medium of embodiment 27, wherein the executable program stores additional instructions to:

[0219] In response to an indication that the second analyte sensor is not effectively calibrated, repeating the cross-calibration process and comparing the first analyte value to the second analyte value until it is determined that the second analyte sensor is effectively calibrated and the first analyte sensor can be removed from the subject.

[0220] Embodiment 29. The non-transitory computer-readable storage medium of embodiment 26, wherein the executable program stores additional instructions to:

[0221] determining an appropriate amount of insulin to be injected into the subject based on the second analyte value, wherein each of the first analyte sensor and the second analyte sensor is a glucose biosensor; and

[0222] Wherein, the first analyte value and the second analyte value each correspond to a blood glucose value.

[0223] Embodiment 30. A non-transitory computer-readable storage medium according to Embodiment 26, wherein the duration is between one hour and twelve hours.

[0224] Embodiment 31. The non-transitory computer-readable storage medium of embodiment 26, wherein the executable program stores additional instructions to:

[0225] generating an analyte sensitivity based at least in part on the second analyte value for the second analyte sensor during the duration;

[0226] retrieving one or more analyte sensor performance parameters from previous analyte sensor wear periods of the subject, the one or more analyte sensor performance parameters comprising an analyte sensitivity determination data set corresponding to a plurality of previously worn analyte sensors and a background current data set; and

[0227] One or more calibration processes that rely on one or more of the background current data set and the analyte sensitivity determination data set are implemented to improve the accuracy of the analyte sensitivity for the second analyte sensor.

[0228] Although certain embodiments have been shown and described herein, it will be appreciated by those of ordinary skill in the art that various alternative and / or equivalent embodiments or implementations calculated to achieve the same purpose may replace the embodiments shown and described without departing from the scope. It will be readily appreciated by those skilled in the art that embodiments may be implemented in a variety of ways. The present application is intended to encompass any modifications or variations of the embodiments discussed herein. Therefore, it is clearly intended that the embodiments be limited only by the claims and their equivalents.

Claims

1. An apparatus comprising at least one processor configured to perform operations comprising: measuring, for a first duration, a first current from a first biosensor and a second current from a second biosensor, the first biosensor having been inserted into tissue of a subject prior to insertion of the second biosensor; converting the first current into a first analyte value; comparing the first current to the second current; as well as A second analyte value is generated for the second biosensor based on the comparison, thereby calibrating the second biosensor.

2. The device according to claim 1, wherein: The first biosensor is inserted into tissue of a subject at least one day but less than thirty days prior to the insertion of the second biosensor.

3. The apparatus of claim 1, the operations further comprising calibrating the first biosensor before initiating calibration of the second biosensor, wherein: The first biosensor is calibrated based on one or more blood analyte values ​​obtained from the subject's blood.

4. The device according to claim 1, wherein: The first duration is at least one minute and no more than sixty minutes; and Converting the first current into the first analyte value occurs between five seconds and sixty seconds from the start of the first duration.

5. The device according to claim 1, wherein: Comparing the first current to the second current and generating the second analyte value further comprises: predicting a first background current over a second duration, the first background current being a portion of the second current as a function of time, the second duration extending beyond the first duration, wherein the second current is measured during the second duration; subtracting the first background current from the second current measured during the second duration to obtain a subtracted second current; and Based at least in part on one or more of the first current and the first analyte value, a conversion process is constructed, the conversion process for generating the second analyte value for the second biosensor.

6. The device according to claim 5, wherein: The first background current is predicted based at least in part on one or more of the second current, the first current, and the first analyte value.

7. The device according to claim 5, wherein: The second duration extends to twelve hours after insertion of the second biosensor.

8. The device according to claim 5, wherein: Comparing the first current to the second current and generating the second analyte value further comprises: predicting a second background current over a third duration, the second background current being a portion of the second current as a function of time, the third duration extending beyond the first duration and the second duration, and wherein the second current is measured during the third duration; subtracting the second background current from the second current measured during the third duration to obtain the subtracted second current; and The second analyte value is generated for the second biosensor using the conversion process based on the subtracted second current determined during the third duration as an input.

9. The apparatus of claim 8, wherein the operations further comprise: retrieving historical data related to analyte sensitivity for one or more other biosensors previously worn by the subject; as well as A correction factor derived from the analyte sensitivity is applied in generating the second analyte value to increase the sensitivity of the second biosensor.

10. The device according to claim 1, wherein: Each of the first biosensor and the second biosensor comprises a glucose biosensor; and The first analyte value and the second analyte value each correspond to one or more glucose values.

11. A system comprising: The first glucose biosensor; a second glucose biosensor; as well as A mobile computing device, the mobile computing device being configured to: receiving an indication that the second glucose biosensor has been inserted into the subject, if the first glucose biosensor has been inserted into the subject; initiating a cross-calibration process within a determined amount of time after receiving said indication; obtaining a first current from the first glucose biosensor and a second current from the second glucose biosensor; converting the first current into a first glucose value; predicting a background current associated with the second glucose biosensor based at least in part on the first current, the second current, and the first glucose value; subtracting the background current from the second current to obtain a subtracted second current; creating a conversion operation for converting the subtracted second current into a second glucose value, the conversion operation being based at least in part on one or more of the first current and the first glucose value; converting the subtracted second current into the second glucose value based on the converting operation; as well as A set of instructions related to delivering insulin to the subject is provided based on the second glucose value.

12. The system according to claim 11, further comprising: an insulin delivery unit in communication with the mobile computing device, the insulin delivery unit comprising at least an insulin pump and an infusion set, the infusion set being fluidly coupled to the insulin pump via tubing, wherein the mobile computing device is further configured to send the set of instructions to the insulin delivery unit for delivering the insulin to the subject via the infusion set by controlling operation of the insulin pump.

13. The system according to claim 11, wherein: The mobile computing device also includes a display; and Providing the set of instructions includes transmitting, via the display, the set of instructions related to delivering insulin to the subject.

14. The system according to claim 11, wherein: The mobile computing device is further configured to: comparing the first glucose value to the second glucose value; and In response to an indication that the second glucose value correlates within a predetermined threshold of the first glucose value, providing the set of instructions related to delivering insulin to the subject based on the second glucose value.

15. The system of claim 14, wherein: The mobile computing device is further configured to: Responsive to an indication that the second glucose value correlates within the predetermined threshold of the first glucose value, an alert is provided to the subject that the first glucose biosensor can be removed.

16. The system according to claim 11, wherein: The mobile computing device is further configured to: predicting the background current between one minute and 60 minutes after initiating the cross-calibration process; subtracting the background current from the second current; as well as The subtracted second current is converted to the second glucose value based on the converting operation up to two days after initiating the cross-calibration process.

17. A device comprising: at least one processor; as well as A memory storing instructions, which, when executed by the at least one processor, cause the device to perform operations including: detecting insertion of a second sensor into tissue of a subject with the first sensor inserted into the tissue; In response to the detecting, initiating a cross-calibration process of the second sensor; obtaining a first current from the first sensor and a second current from the second sensor; converting the first current into a first analyte value; responsive to an indication that a predetermined condition for modeling a first non-glucose driven background current associated with the second sensor is satisfied, predicting the first non-glucose driven background current for the second sensor for a first duration; subtracting the first non-glucose driven background current from the second current during the first duration to obtain a subtracted second current for the second sensor; as well as The subtracted second current is converted into a second analyte value.

18. The apparatus according to claim 17, wherein: The operations also include predicting the first non-glucose driven background current based at least in part on (i) the second current measured before the predetermined condition is satisfied and (ii) one or more of the first current and the first analyte value obtained before the predetermined condition is satisfied.

19. The apparatus according to claim 18, wherein: The operations further include predicting the first non-glucose driven background current based at least in part on previously generated patterns of background current variations over time learned from a plurality of other analyte sensors inserted into the subject at an earlier time.

20. The apparatus of claim 17, wherein: an indication that a predetermined condition for modeling the first non-glucose driven background current is satisfied occurs between one minute and sixty minutes after initiation of the cross-calibration process; and The first duration during which the first non-glucose driven background current is subtracted from the second current is at least two hours and up to sixty-four hours.

21. The apparatus of claim 17, wherein: The operations also include: modeling a second non-glucose driven background current associated with the second sensor for a second duration extending beyond the first duration; obtaining the second current from the second sensor during the second duration; subtracting the second non-glucose driven background current from the second current measured during the second duration to obtain the subtracted second current for the second sensor; and The subtracted second current is converted into the second analyte value.

22. The apparatus according to claim 21, wherein The second duration during which the second non-glucose driven background current is subtracted from the second current is at least 15 days and up to 32 days.

23. The apparatus of claim 21, wherein: The operations also include modeling the second non-glucose driven background current based on data retrieved from one or more analyte sensors previously worn by the subject that are of the same type as each of the first sensor and the second sensor.

24. The apparatus of claim 21, wherein: Obtaining the subtracted second current and converting the subtracted second current into the second analyte value further comprises: recalling one or more previously learned analyte sensitivity values ​​from previous use of other analyte sensors by the subject; and A calibration process is applied to obtain accurate analyte sensitivity for the second sensor.

25. The apparatus of claim 21, wherein: The operations also include generating a conversion operation including one or more conversion parameters and for converting the subtracted second current to the second analyte value during each of the first duration and the second duration; wherein each of the first duration and the second duration is variable and terminates in response to an indication that the converting operation accurately converts the subtracted current to the second analyte value during each of the first duration and the second duration; and The one or more conversion parameters for the conversion operation are the same or different between the first duration and the second duration.

26. A method comprising: detecting that a second analyte sensor has been inserted into the skin of the subject after inserting a first analyte sensor into the skin of the subject, wherein the insertion of the first analyte sensor occurred between one day and thirty days before the insertion of the second analyte sensor; initiating a cross-calibration process based on the detection; retrieving a first current from the first analyte sensor and a second current from the second analyte sensor, and converting the first current to a first analyte value within five seconds to sixty seconds of initiating the cross-calibration process; determining, within sixty seconds to one hour after initiating the cross-calibration procedure, that a current decay trend can be established for the second analyte sensor based on the second current, and in response, predicting an extrapolated background current over a duration based at least in part on the second current measured within sixty seconds to one hour after initiating the cross-calibration procedure; subtracting the background current from the second current to obtain a subtracted second current during the duration; as well as The subtracted second current is converted into a second analyte value, thereby calibrating the second analyte sensor.

27. The method according to claim 26, further comprising: converting the first current into the first analyte value during the duration; comparing the first analyte value to the second analyte value during the duration; as well as In response to the first analyte value obtained during the duration correlating within a predetermined threshold of the second analyte value, it is determined that the second analyte sensor is effectively calibrated and the first analyte sensor can be removed.

28. The method according to claim 27, further comprising: in response to an indication that the second analyte sensor is not effectively calibrated, repeating the cross-calibration process; as well as The first analyte value is compared to the second analyte value until the second analyte sensor is effectively calibrated and can be removed from the subject.

29. The method of claim 26, further comprising: Based on the second analyte value, determining an appropriate amount of insulin to be injected into the subject, wherein: Each of the first analyte sensor and the second analyte sensor is a glucose biosensor; and The first analyte value and the second analyte value each correspond to a blood glucose value.

30. The method of claim 26, wherein: The duration is between one and twelve hours.

31. The method of claim 26, further comprising: generating an analyte sensitivity based at least in part on the second analyte value for the second analyte sensor during the duration; retrieving one or more analyte sensor performance parameters from previous analyte sensor wear periods of the subject, the one or more analyte sensor performance parameters comprising an analyte sensitivity determination data set corresponding to a plurality of previously worn analyte sensors and a background current data set; as well as One or more calibration processes that rely on one or more of the background current data set and the analyte sensitivity determination data set are implemented to improve the accuracy of the analyte sensitivity for the second analyte sensor.